<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non‐invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema - Berbenetz, N - 2019 | Cochrane Library</title> <meta content="Non‐invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema - Berbenetz, N - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005351.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non‐invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema - Berbenetz, N - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005351.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005351.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Non‐invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema" name="citation_title"/> <meta content="Nicolas Berbenetz" name="citation_author"/> <meta content="Queen’s University" name="citation_author_institution"/> <meta content="nberbenetz@gmail.com" name="citation_author_email"/> <meta content="Yongjun Wang" name="citation_author"/> <meta content="Schulich School of Medicine &amp; Dentistry, Western University" name="citation_author_institution"/> <meta content="James Brown" name="citation_author"/> <meta content="Royal Free Hospital" name="citation_author_institution"/> <meta content="Charlotte Godfrey" name="citation_author"/> <meta content="St Helier Hospital" name="citation_author_institution"/> <meta content="Mahmood Ahmad" name="citation_author"/> <meta content="Royal Free Hospital, Royal Free London NHS Foundation Trust" name="citation_author_institution"/> <meta content="Flávia MR Vital" name="citation_author"/> <meta content="Cochrane Brazil Minas Gerais" name="citation_author_institution"/> <meta content="Pier Lambiase" name="citation_author"/> <meta content="The Heart Hospital, University College London Hospitals" name="citation_author_institution"/> <meta content="Amitava Banerjee" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Ameet Bakhai" name="citation_author"/> <meta content="Royal Free London NHS Foundation Trust" name="citation_author_institution"/> <meta content="Matthew Chong" name="citation_author"/> <meta content="Western University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD005351.pub4" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/04/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005351.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005351.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005351.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Hospital Mortality; Continuous Positive Airway Pressure [adverse effects, *methods]; Intensive Care Units; Intubation, Intratracheal [statistics &amp; numerical data]; Length of Stay; Noninvasive Ventilation; Pulmonary Edema [*therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005351.pub4&amp;doi=10.1002/14651858.CD005351.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZCrlluee";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005351\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005351\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ru","ms","ja","hr","fr","fa","pt"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005351.pub4",title:"Non\\u2010invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema",firstPublishedDate:"Apr 5, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZCrlluee&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005351.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005351.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005351.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005351.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005351.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005351.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005351.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005351.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005351.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005351.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>30336 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005351.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-sec-0103"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-sec-0069"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-sec-0097"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/appendices#CD005351-sec-0108"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/table_n/CD005351StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/table_n/CD005351StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non‐invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#CD005351-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Nicolas Berbenetz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#CD005351-cr-0003">Yongjun Wang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#CD005351-cr-0004">James Brown</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#CD005351-cr-0005">Charlotte Godfrey</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#CD005351-cr-0006">Mahmood Ahmad</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#CD005351-cr-0007">Flávia MR Vital</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#CD005351-cr-0008">Pier Lambiase</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#CD005351-cr-0009">Amitava Banerjee</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#CD005351-cr-0010">Ameet Bakhai</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information#CD005351-cr-0011">Matthew Chong</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information/en#CD005351-sec-0113">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 April 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005351.pub4">https://doi.org/10.1002/14651858.CD005351.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005351-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005351-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005351-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005351-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005351-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD005351-abs-0016">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005351-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005351-abs-0001" lang="en"> <section id="CD005351-sec-0001"> <h3 class="title" id="CD005351-sec-0001">Background</h3> <p>Non‐invasive positive pressure ventilation (NPPV) has been used to treat respiratory distress due to acute cardiogenic pulmonary oedema (ACPE). We performed a systematic review and meta‐analysis update on NPPV for adults presenting with ACPE. </p> </section> <section id="CD005351-sec-0002"> <h3 class="title" id="CD005351-sec-0002">Objectives</h3> <p>To evaluate the safety and effectiveness of NPPV compared to standard medical care (SMC) for adults with ACPE. The primary outcome was hospital mortality. Important secondary outcomes were endotracheal intubation, treatment intolerance, hospital and intensive care unit length of stay, rates of acute myocardial infarction, and adverse event rates. </p> </section> <section id="CD005351-sec-0003"> <h3 class="title" id="CD005351-sec-0003">Search methods</h3> <p>We searched CENTRAL (CRS Web, 20 September 2018), MEDLINE (Ovid, 1946 to 19 September 2018), Embase (Ovid, 1974 to 19 September 2018), CINAHL Plus (EBSCO, 1937 to 19 September 2018), LILACS, WHO ICTRP, and clinicaltrials.gov. We also reviewed reference lists of included studies. We applied no language restrictions. </p> </section> <section id="CD005351-sec-0004"> <h3 class="title" id="CD005351-sec-0004">Selection criteria</h3> <p>We included blinded or unblinded randomised controlled trials in adults with ACPE. Participants had to be randomised to NPPV (continuous positive airway pressure (CPAP) or bilevel NPPV) plus standard medical care (SMC) compared with SMC alone. </p> </section> <section id="CD005351-sec-0005"> <h3 class="title" id="CD005351-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened and selected articles for inclusion. We extracted data with a standardised data collection form. We evaluated the risks of bias of each study using the Cochrane 'Risk of bias' tool. We assessed evidence quality for each outcome using the GRADE recommendations. </p> </section> <section id="CD005351-sec-0006"> <h3 class="title" id="CD005351-sec-0006">Main results</h3> <p>We included 24 studies (2664 participants) of adult participants (older than 18 years of age) with respiratory distress due to ACPE, not requiring immediate mechanical ventilation. People with ACPE presented either to an Emergency Department or were inpatients. ACPE treatment was provided in an intensive care or Emergency Department setting. There was a median follow‐up of 13 days for hospital mortality, one day for endotracheal intubation, and three days for acute myocardial infarction. Compared with SMC, NPPV may reduce hospital mortality (risk ratio (RR) 0.65, 95% confidence interval (CI) 0.51 to 0.82; participants = 2484; studies = 21; I<sup>2</sup> = 6%; low quality of evidence) with a number needed to treat for an additional beneficial outcome (NNTB) of 17 (NNTB 12 to 32). NPPV probably reduces endotracheal intubation rates (RR 0.49, 95% CI 0.38 to 0.62; participants = 2449; studies = 20; I<sup>2</sup> = 0%; moderate quality of evidence) with a NNTB of 13 (NNTB 11 to 18). There is probably little or no difference in acute myocardial infarction (AMI) incidence with NPPV compared to SMC for ACPE (RR 1.03, 95% CI 0.91 to 1.16; participants = 1313; studies = 5; I<sup>2</sup> = 0%; moderate quality of evidence). We are uncertain as to whether NPPV increases hospital length of stay (mean difference (MD) −0.31 days, 95% CI −1.23 to 0.61; participants = 1714; studies = 11; I<sup>2</sup> = 55%; very low quality of evidence). Adverse events were generally similar between NPPV and SMC groups, but evidence was of low quality. </p> </section> <section id="CD005351-sec-0007"> <h3 class="title" id="CD005351-sec-0007">Authors' conclusions</h3> <p>Our review provides support for continued clinical application of NPPV for ACPE, to improve outcomes such as hospital mortality and intubation rates. NPPV is a safe intervention with similar adverse event rates to SMC alone. Additional research is needed to determine if specific subgroups of people with ACPE have greater benefit of NPPV compared to SMC. Future research should explore the benefit of NPPV for ACPE patients with hypercapnia. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005351-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005351-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005351-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005351-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005351-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD005351-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD005351-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD005351-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD005351-abs-0017">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD005351-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005351-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD005351-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005351-abs-0004" lang="en"> <h3>A breathing intervention for shortness of breath due to heart failure</h3> <p><b>Background</b> </p> <p>Heart failure is one of the leading causes of hospital admission in the world. People with heart failure often experience shortness of breath and leg swelling. These symptoms may develop over hours to weeks, or rapidly over a few hours. Such rapid deterioration is called acute cardiogenic pulmonary oedema. </p> <p>Providing air under pressure through a face or nose mask can treat shortness of breath. This treatment is called non‐invasive ventilation and its use in heart failure is controversial. </p> <p><b>Study characteristics</b> </p> <p>Randomised controlled studies compare treatments to find out if they are truly effective. We searched for randomised studies comparing non‐invasive ventilation to routine care for adults with acute cardiogenic pulmonary oedema. We compared studies treating people with non‐invasive ventilation versus medical care. Medical care includes therapies such as providing extra oxygen and water pills to patients. The evidence upon which this review is based is current to September 2018. </p> <p><b>Review question</b> </p> <p>We sought to address if non‐invasive ventilation in adults with acute cardiogenic pulmonary oedema reduces rates of deaths, the need for a breathing tube, and heart attacks. </p> <p><b>Key results and quality of evidence</b> </p> <p>We found 24 studies with 2664 participants comparing non‐invasive ventilation to medical care alone. Non‐invasive ventilation may decrease the chances of dying in hospital. The quality of results for studies reporting death in hospital was low. Studies were poorly conducted, and results were not similar across studies. In addition, non‐invasive ventilation probably reduces the chances of needing a breathing tube. The quality of results for studies reporting breathing tube rates was moderate. Studies evaluating breathing tube rates were poorly conducted. Non‐invasive ventilation probably has little or no effect on getting a heart attack. The quality of results for studies reporting heart attack rates was moderate, and studies had inconsistent results for this outcome. We are unsure if the length of hospital stay is improved with non‐invasive ventilation. The quality of results for studies reporting hospital length of stay was very low, which was due to poor study conduct and inconsistent results. Finally, non‐invasive ventilation may make little or no difference to adverse events (complications), compared to medical care. The quality of results for studies reporting adverse events was low. Studies evaluating adverse events were poorly conducted and had inconsistent results. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005351-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005351-sec-0103"></div> <h3 class="title" id="CD005351-sec-0104">Implications for practice</h3> <section id="CD005351-sec-0104"> <p>Meta‐analysis of the best available evidence for NPPV versus SMC to treat ACPE demonstrates that NPPV may reduce hospital mortality and probably reduces ETI. NPPV probably has little or no influence on rates of AMI compared to SMC. We are uncertain whether NPPV reduces hospital length of stay compared to SMC. When considering the type of NPPV, the included studies demonstrated no significant differences between CPAP or bilevel NPPV compared to SMC. Thus, it is reasonable to consider the initiation of NPPV in people with ACPE who are already receiving optimal SMC. Limitations in the current evidence did not allow us to identify patient subgroups (e.g., eucapnic people or people treated in the ER or ICU) that derived more (or less) benefit from the initiation of NPPV. </p> </section> <h3 class="title" id="CD005351-sec-0105">Implications for research</h3> <section id="CD005351-sec-0105"> <p>Current evidence has allowed us to draw conclusions about the efficacy of NPPV (versus SMC) for treating ACPE. Nevertheless, certain shortcomings of the included studies have left some clinical questions unanswered. First, the optimal dosing of diuretics as part of SMC was not clear within the included studies. It is possible that the benefits of NPPV identified herein may be different (e.g. reduced or null), based on the clinical experience of a clinician providing SMC for ACPE. Second, it remains to be seen if certain types of people with ACPE (e.g. those with more severe ACC/AHA heart failure grade) would derive more benefit from the initiation of NPPV (in addition to SMC). Future studies should be judicious about explicitly defining intubation criteria, characterising the aetiology of ACPE, the underlying severity of heart failure, and guideline adherence for home heart‐failure therapies prior to admission. Finally, individual patient‐level data for blood gases with prespecified subgroups for hypercapnia or eucapnia can better characterise whether NPPV influences clinically important outcomes to a greater degree in people with hypercapnia compared to eucapnia. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005351-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005351-sec-0036"></div> <div class="table" id="CD005351-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">NPPV compared to SMC for cardiogenic pulmonary oedema</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>NPPV compared to standard medical care for cardiogenic pulmonary oedema</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> People with cardiogenic pulmonary oedema<br/> <b>Setting:</b> Pre‐hospital intensive care, emergency department, coronary care unit, or intensive care unit<br/> <b>Intervention:</b> NPPV<br/> <b>Comparison:</b> Standard medical care (SMC) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with SMC</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with NPPV</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>HOSPITAL MORTALITY<br/> follow‐up: median 13 days; range 1 day ‐ 41 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.65<br/> (0.51 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2484<br/> (21 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>176 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>114 per 1000<br/> (90 to 144) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ETI RATE<br/> follow‐up: median 1 day; </p> <p>range 0.1 day ‐ 30 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.49<br/> (0.38 to 0.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2449<br/> (20 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>154 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>75 per 1000<br/> (58 to 95) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ACUTE MI INCIDENCE<br/> follow‐up: median 3 days; range 1 day ‐ 41 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.91 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1313<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>421 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>433 per 1000<br/> (383 to 488) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HOSPITAL LENGTH OF STAY</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean HOSPITAL LENGTH OF STAY was 9.65 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.31 days lower<br/> (1.23 lower to 0.61 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1714<br/> (11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>e,f,g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU LENGTH OF STAY</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>This outcome could not be pooled due to high heterogeneity. There was no evidence of a difference between NPPV and SMC in 4 RCTs, and 2 RCTs reported a shorter length of stay for NPPV (1 day shorter (95% CI −1.79 to −0.21); n = 30; 4 days shorter (95% CI −4.36 to −3.64); n = 120) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>587<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>h,i,j</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were not pooled due to high heterogeneity with an I<sup>2</sup> of 99% </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>INTOLERANCE TO ALLOCATED TREATMENT ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ADVERSE EVENTS</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Reported adverse events included skin damage, pneumonia, gastrointestinal bleeding, gastric distention, vomiting, pneumothorax, sinusitis, mask discomfort, hypotension, arrhythmia, cardiorespiratory arrest, gastric aspiration, stroke, seizures, claustrophobia, and hypercapnia. </p> <p>There was no evidence of a difference between groups for most of these events. However, there was an increase in discomfort with mask reported with NPPV (35/658) compared with SMC (0/442); RR 12.59 (95% CI 2.39 to 66.28). </p> <p>One small study (n = 83) reported a higher incidence of gastric distention in the NPPV group (13/56 in NPPV group, 0/27 in SMC group; RR 13.26 (95% CI 0.82 to 215.12)), but the number of events was low and the confidence interval wide. There was also some weak evidence of a lower incidence of cardiorespiratory arrest in the NPPV group (24/836 (NPPV) vs 26/516 (SMC); RR 0.60 (95% CI 0.34 to 1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2038<br/> (11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>k,l</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for risk of bias. Most trials providing hospital mortality evidence were at unclear or high risk of bias for key domains, including: randomisation sequence, allocation concealment, selective reporting bias, and other significant bias.<br/> <sup>b</sup>Downgraded by one level for imprecision. Most trials had few participants and few mortality events, with a confidence interval crossing a RR of 0.75.<br/> <sup>c</sup>Downgraded by one level for risk of bias. Most trials providing ETI evidence were rated as having unclear or high risk of bias for key domains, which included randomisation sequence generation, allocation concealment, selective reporting bias, and other significant bias.<br/> <sup>d</sup>Downgraded by one level for imprecision. Most trials had few participants and few acute MI events, with a confidence interval crossing a RR of 1.0. In addition, the definition of acute MI varied between trials, with some trials using creatinine kinase and others using troponin.<br/> <sup>e</sup>Downgraded by one level for risk of bias. Most trials were at low or unclear risk of bias. Potential limitations from lack of blinding are likely to lower confidence in hospital length of stay.<br/> <sup>f</sup>Downgraded by one level for inconsistency. Hospital length of stay was heterogeneous, with an I<sup>2</sup> of 58% and visually‐evident heterogeneity.<br/> <sup>g</sup>Downgraded by one level for imprecision. Most trials had few participants, with a confidence interval crossing a MD of 0.<br/> <sup>h</sup>Downgraded by one level for risk of bias. Most information was from studies at low or unclear risk of bias. Potential limitations from lack of blinding are likely to lower confidence in ICU length of stay.<br/> <sup>i</sup>Downgraded by one level for imprecision. Most trials had few participants, with a confidence interval crossing a MD of 0.<br/> <sup>j</sup>Downgraded by one level for inconsistency. ICU length of stay was heterogeneous, with an I<sup>2</sup> of 99% and visually‐evident heterogeneity.<br/> <sup>k</sup>Downgraded by one level for risk of bias. Most studies had at least one domain at high or unclear risk of bias.<br/> <sup>l</sup>Downgraded by one level for imprecision, as confidence intervals included both directions of effect for many of the adverse events. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005351-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005351-sec-0037"></div> <section id="CD005351-sec-0038"> <h3 class="title" id="CD005351-sec-0038">Description of the condition</h3> <p>Abnormal heart function in heart failure (HF) can produce signs and symptoms of reduced cardiac output (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>). A rapid deterioration in HF symptoms is called congestive heart failure (CHF) or acute cardiogenic pulmonary oedema (ACPE). Symptoms of ACPE can include dyspnoea, orthopnoea, peripheral oedema, cough, fatigue, and weight gain (<a href="./references#CD005351-bbs2-0103" title="WangCS , FitzGeraldJM , SchulzerM , MakE , AyasNT . Does this dyspneic patient in the emergency department have congestive heart failure?. JAMA2005;294(15):1944‐56. [DOI: 10.1001/jama.294.15.1944; MEDLINE: 16234501] ">Wang 2005</a>). Signs of ACPE can include the presence of a third heart sound, jugular venous distension, rales, lower extremity oedema, wheezing, and ascites (<a href="./references#CD005351-bbs2-0103" title="WangCS , FitzGeraldJM , SchulzerM , MakE , AyasNT . Does this dyspneic patient in the emergency department have congestive heart failure?. JAMA2005;294(15):1944‐56. [DOI: 10.1001/jama.294.15.1944; MEDLINE: 16234501] ">Wang 2005</a>). Approximately one million people a year are discharged from hospitals in the United States with HF (<a href="./references#CD005351-bbs2-0071" title="BenjaminEJ , BlahaMJ , ChiuveSE , CushmanM , DasSR , DeoR , et al. Heart disease and stroke statistics‐2017 Update: A report From the American Heart Association. Circulation2017;135(10):e146‐603. [PUBMED: 28122885] ">Benjamin 2017</a>). ACPE severity is variable, but the presence of hypoxia, respiratory failure, and hypotension can indicate a higher risk presentation (<a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>). Many conditions can trigger ACPE, such as acute coronary syndrome (ACS), tachyarrhythmia, valvular heart disease, and hypertension (<a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>). Importantly, ACPE is also associated with an in‐hospital mortality of approximately 10% and one‐year mortality of 30% (<a href="./references#CD005351-bbs2-0098" title="RudigerA , HarjolaVP , MullerA , MattilaE , SailaP , NieminenM , et al. Acute heart failure: clinical presentation, one‐year mortality and prognostic factors. European Journal of Heart Failure2005;7(4):662‐70. [PUBMED: 15921809] ">Rudiger 2005</a>). </p> <p>ACPE can be conceptualised as left ventricular failure with elevated left ventricular filling pressures. Elevated filling pressures produce higher pulmonary capillary pressures and fluid extravasation into alveoli due to overwhelmed lymphatic vessel absorption capacity (<a href="./references#CD005351-bbs2-0068" title="AllisonRC . Initial treatment of pulmonary edema: a physiological approach. American Journal of the Medical Sciences1991;302(6):385‐91. [MEDLINE: 1772126] ">Allison 1991</a>; <a href="./references#CD005351-bbs2-0092" title="PackerM . How should physicians view heart‐failure ‐ the philosophical and physiological evolution of 3 conceptual models of the disease. American Journal of Cardiology1993;71(9):C3‐C11. [DOI: 10.1016/0002‐9149(93)90081‐M] ">Packer 1993</a>). Pulmonary oedema fluid can dilute surfactant and neutralise its lubricating properties, causing a reduction in lung compliance and increased work of breathing (<a href="./references#CD005351-bbs2-0068" title="AllisonRC . Initial treatment of pulmonary edema: a physiological approach. American Journal of the Medical Sciences1991;302(6):385‐91. [MEDLINE: 1772126] ">Allison 1991</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>). In the upright position, oedema accumulates at the lung bases, causing a ventilation‐perfusion (V‐Q) mismatch, which can cause hypoxia (<a href="./references#CD005351-bbs2-0068" title="AllisonRC . Initial treatment of pulmonary edema: a physiological approach. American Journal of the Medical Sciences1991;302(6):385‐91. [MEDLINE: 1772126] ">Allison 1991</a>). </p> </section> <section id="CD005351-sec-0039"> <h3 class="title" id="CD005351-sec-0039">Description of the intervention</h3> <p>ACPE treatment guidelines have been prepared in several countries, including Canada (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>) and Europe (<a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>). Treatment options include: loop diuretics (e.g. furosemide), vasodilators (e.g. nitroglycerin), supplemental oxygen, non‐invasive positive pressure ventilation (NPPV), and endotracheal intubation (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>; <a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>). Treating the underlying cause of ACPE is also necessary (e.g. antihypertensives for hypertension, coronary angiography for ST elevation myocardial infarction) (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>; <a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>; <a href="./references#CD005351-bbs2-0106" title="YancyCW , JessupM , BozkurtB , ButlerJ , CaseyDEJr , DraznerMH , et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation2013;128(16):e240‐327. [DOI: 10.1161/CIR.0b013e31829e8776] ">Yancy 2013</a>). </p> <p>Endotracheal intubation raises the risk for adverse events, such as nosocomial infections (e.g. pneumonia), tracheal injury, and prolonged hospital length of stay (<a href="./references#CD005351-bbs2-0076" title="GayPC . Complications of noninvasive ventilation in acute care. Respiratory Care2009;54(2):246–57. [MEDLINE: 19173756] ">Gay 2009</a>). In contrast to the invasiveness of endotracheal intubation, NPPV can be provided in the form of continuous positive airway pressure (CPAP) and bilevel NPPV (BiPAP® ‐ Respironics, Inc, Murrysville, PA) using face or nasal masks. CPAP maintains a constant positive airway pressure throughout the respiratory cycle. In contrast, bilevel NPPV provides additional inspiratory positive airway pressure and positive end‐expiratory pressure (<a href="./references#CD005351-bbs2-0091" title="NavaS , HillN . Non‐invasive ventilation in acute respiratory failure. Lancet2009;374(9685):250‐9. [DOI: 10.1016/S0140‐6736(09)60496‐7] ">Nava 2009</a>). </p> </section> <section id="CD005351-sec-0040"> <h3 class="title" id="CD005351-sec-0040">How the intervention might work</h3> <p>The cardiovascular and pulmonary systems work together to maintain homeostasis. During normal inhalation contraction of the diaphragm and intercostal muscles produces a more negative pleural pressure compared to the lungs at rest (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>). This negative pleural pressure reduces left ventricular pressure relative to systemic arterial pressure (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>). In contrast, during positive pressure ventilation, inhalation involves a positive pleural pressure which raises left ventricular pressure relative to systemic arterial pressure and reduces left ventricular afterload due to a baroreceptor reflex (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>; <a href="./references#CD005351-bbs2-0072" title="BudaAJ , PinskyMR , IngelsNBJr , DaughtersGT , StinsonEB , AldermanEL . Effect of intrathoracic pressure on left ventricular performance. New England Journal of Medicine1979;301(9):453‐9. [DOI: 10.1056/NEJM197908303010901] ">Buda 1979</a>). Intrapleural pressure influences right ventricular inflow and left ventricular outflow. The difference between airway pressure and intrapleural pressure (transpulmonary pressure gradient) affects pulmonary vasculature, which in turn influences left ventricular inflow and right ventricular outflow (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>). NPPV reduces pulmonary workload, improves cardiac output, and enhances lung compliance (<a href="./references#CD005351-bbs2-0027" title="BaratzDM , WestbrookPR , ShahPK , MohsenifarZ . Effect of nasal continuous positive airway pressure on cardiac output and oxygen delivery in patients with congestive heart failure. Chest1992;102(5):1397‐401. [PUBMED: 1424858] ">Baratz 1992</a>; <a href="./references#CD005351-bbs2-0085" title="LeniqueF , HabisM , LofasoF , Dubois‐RandeJL , HarfA , BrochardL . Ventilatory and haemodynamic effects of continuous positive airway pressure in left heart failure. American Journal of Respiratory and Critical Care Medicine1997;155(2):500‐5. [DOI: 10.1164/ajrccm.155.2.9032185] ">Lenique 1997</a>). During ACPE interstitial and alveolar oedema reduce lung compliance. Application of positive pressure at end expiration can force fluid out of alveoli, improving pulmonary vascular resistance and enhancing gas exchange (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>). In addition, positive pressure ventilation could prevent alveolar collapse and enhance alveolar expansion with inspiration improving airway compliance (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>). This mechanism could explain how NPPV applied during ACPE can lead to improved oxygenation (<a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>). During respiratory distress without NPPV the intrapleural pressure becomes more negative and left ventricular afterload is increased, because left ventricular systolic pressure is more negative compared to the systemic circulation (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>; <a href="./references#CD005351-bbs2-0087" title="MagderSA , LichtensteinS , AdelmanAG . Effect of negative pleural pressure on left ventricular hemodynamics. American Journal of Cardiology1983;52(5):588‐93. [MEDLINE: 6613883] ">Magder 1983</a>). In terms of left ventricular function, NPPV reduces preload, afterload, myocardial oxygen demand, and enhances hydrostatic displacement of alveolar oedema (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>). In left ventricular failure, NPPV can improve cardiac output by reducing left ventricular afterload. In contrast, in right ventricular failure, NPPV reduces right ventricular preload and can reduce right ventricular cardiac output (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>). The net benefit of NPPV in heart failure will depend on the relative left and right ventricular functions, and afterload (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>). Furthermore, NPPV use in ACPE may prevent endotracheal intubation without significant adverse events (<a href="./references#CD005351-bbs2-0091" title="NavaS , HillN . Non‐invasive ventilation in acute respiratory failure. Lancet2009;374(9685):250‐9. [DOI: 10.1016/S0140‐6736(09)60496‐7] ">Nava 2009</a>). Mechanical ventilation can be life‐saving for people with respiratory failure needing airway protection and with severe hypoxia associated with failed NPPV therapy (<a href="./references#CD005351-bbs2-0069" title="AlviarCL , MillerPE , McAreaveyD , KatzJN , LeeB , MoriyamaB , et al. ACC Critical Care Cardiology Working Group. Positive pressure ventilation in the cardiac intensive care unit. Journal of the American College of Cardiology2018;72(13):1532‐53. [DOI: 10.1016/j.jacc.2018.06.074] ">Alviar 2018</a>). However, mechanical ventilation is associated with additional adverse events, such as endotracheal tube complications (<a href="./references#CD005351-bbs2-0102" title="TobinMJ . Mechanical ventilation. New England Journal of Medicine1994;330(15):1056‐61. [DOI: 10.1056/NEJM199404143301507] ">Tobin 1994</a>), ventilator‐associated lung injury (<a href="./references#CD005351-bbs2-0099" title="SlutskyAS , RanieriVM . Ventilator‐induced lung injury. New England Journal of Medicine2013;369(22):2126‐36. [MEDLINE: 24283226] ">Slutsky 2013</a>), ventilator‐associated pneumonia (<a href="./references#CD005351-bbs2-0100" title="SpaldingMC , CrippsMW , MinshallCT . Ventilator‐associated pneumonia: new definitions. Critical Care Clinics2017;33(2):277‐92. [DOI: 10.1016/j.ccc.2016.12.009] ">Spalding 2017</a>), barotrauma (e.g. pneumothorax) (<a href="./references#CD005351-bbs2-0070" title="AnzuetoA , Frutos–VivarF , EstebanA , AlíaI , Brochard L. StewartT , et al. Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients. Intensive Care Medicine2004;30(4):612‐9. ">Anzueto 2004</a>), and ventilator‐induced diaphragmatic dysfunction (<a href="./references#CD005351-bbs2-0086" title="LevineS , NguyenT , TaylorN , FrisciaME , BudakMT , RothenbergP . Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans.. New England Journal of Medicine2008;358(13):1327‐35. [DOI: 10.1056/NEJMoa070447] ">Levine 2008</a>). </p> </section> <section id="CD005351-sec-0041"> <h3 class="title" id="CD005351-sec-0041">Why it is important to do this review</h3> <p>Since the increased clinical use of NPPV in the 1980s, many studies have evaluated NPPV's effectiveness for ACPE, and have reported mixed results (<a href="./references#CD005351-bbs2-0091" title="NavaS , HillN . Non‐invasive ventilation in acute respiratory failure. Lancet2009;374(9685):250‐9. [DOI: 10.1016/S0140‐6736(09)60496‐7] ">Nava 2009</a>). Furthermore, current heart failure guidelines differ in their NPPV recommendations. Canadian guidelines recommend against routine use of NPPV, and suggest that NPPV could be used for ACPE with persistent hypoxia despite standard medical care (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>). In addition, Canadian guidelines warn of the clinical risks of NPPV, including worsening right heart failure, worsening hypercapnia, aspiration, and pneumothorax (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>). In contrast, European guidelines (<a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>) suggest NPPV be considered and started quickly in people with ACPE who present with tachypnoea (respiratory rate greater than 25 breaths a minute) and hypoxia (SpO<sub>2</sub> less than 90%). Furthermore, they are of the opinion that NPPV can reduce respiratory distress and endotracheal intubation. The main risk of NPPV emphasised by the European guidelines is hypotension (<a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>). American guidelines do not provide treatment guidance for ACPE (<a href="./references#CD005351-bbs2-0106" title="YancyCW , JessupM , BozkurtB , ButlerJ , CaseyDEJr , DraznerMH , et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation2013;128(16):e240‐327. [DOI: 10.1161/CIR.0b013e31829e8776] ">Yancy 2013</a>). Given the differences in opinion between these two major heart failure guidelines on the use of NPPV for ACPE, we have updated our systematic review and meta‐analysis. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005351-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005351-sec-0042"></div> <p>To evaluate the safety and effectiveness of NPPV compared to standard medical care (SMC) for adults with ACPE. The primary outcome was hospital mortality. Important secondary outcomes were endotracheal intubation, treatment intolerance, hospital and intensive care unit length of stay, rates of acute myocardial infarction, and adverse event rates. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005351-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005351-sec-0043"></div> <section id="CD005351-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005351-sec-0045"> <h4 class="title">Types of studies</h4> <p>For inclusion, studies had to be randomised controlled trials (RCTs). We excluded studies that were cluster‐randomised or used a cross‐over design. We ruled out cluster‐randomised studies to avoid heterogeneity in study design, heterogeneity from the unit of randomisation (e.g. intensive care unit (ICU) versus emergency room (ER)), and variation in eligibility criteria at the individual level compared to a cluster level. We ruled out cross‐over studies because we did not consider them an appropriate design for acute cardiogenic pulmonary oedema (ACPE). In a cross‐over study, a carry‐over effect from the initial therapy (e.g. medical therapy or NPPV) could influence the second intervention (e.g. medical therapy or NPPV), such that participants entering the second intervention differ from those during the first intervention. To avoid publication bias, we included studies irrespective of final publication status. We also included studies reported as full text, abstract only, and unpublished data. </p> </section> <section id="CD005351-sec-0046"> <h4 class="title">Types of participants</h4> <p>We included trials reporting on adults (18 years and older) with ACPE. A diagnosis of ACPE can have symptoms and clinical signs of hypoperfusion or congestion, or both, such as dyspnoea, pulmonary congestion, jugular venous distension, congestive hepatomegaly, peripheral oedema, confusion, oliguria, and cool extremities (<a href="./references#CD005351-bbs2-0103" title="WangCS , FitzGeraldJM , SchulzerM , MakE , AyasNT . Does this dyspneic patient in the emergency department have congestive heart failure?. JAMA2005;294(15):1944‐56. [DOI: 10.1001/jama.294.15.1944; MEDLINE: 16234501] ">Wang 2005</a>; <a href="./references#CD005351-bbs2-0106" title="YancyCW , JessupM , BozkurtB , ButlerJ , CaseyDEJr , DraznerMH , et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation2013;128(16):e240‐327. [DOI: 10.1161/CIR.0b013e31829e8776] ">Yancy 2013</a>). The clinical diagnosis could be supported by a chest radiograph, electrocardiograms, serum biomarkers (e.g. troponin for acute myocardial infarction or Brain natriuretic peptide / N‐terminal‐pro hormone Brain natriuretic peptide for HF), or echocardiography. We excluded trials investigating NPPV for people with a primary diagnosis of pneumonia, alternative aetiologies of respiratory failure (e.g. endocarditis, cardiac surgery patients, unknown cause), or its use as a weaning strategy. </p> </section> <section id="CD005351-sec-0047"> <h4 class="title">Types of interventions</h4> <p>For inclusion, the intervention group had to have received nasal or face mask NPPV (CPAP, or bilevel NPPV, or both) with standard medical care (SMC). In contrast, the control group had to have received the same SMC alone (<a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>; <a href="./references#CD005351-bbs2-0106" title="YancyCW , JessupM , BozkurtB , ButlerJ , CaseyDEJr , DraznerMH , et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation2013;128(16):e240‐327. [DOI: 10.1161/CIR.0b013e31829e8776] ">Yancy 2013</a>). </p> </section> <section id="CD005351-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD005351-sec-0049"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD005351-list-0001"> <li> <p>Hospital mortality</p> </li> </ul> </p> </section> <section id="CD005351-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD005351-list-0002"> <li> <p>Endotracheal intubation</p> </li> <li> <p>Incidence of acute myocardial infarction (AMI) during hospitalisation, after starting treatment, (e.g. cardiac biomarker elevation creatinine kinase (CK) or troponin) with or without electrocardiographic (ECG) changes or symptoms of myocardial ischaemia </p> </li> <li> <p>Intolerance to allocated treatment (e.g. early treatment discontinuation in people not meeting criteria for endotracheal intubation) </p> </li> <li> <p>Treatment failure (the combination of mortality, intubation, and intolerance to the allocated treatment) </p> </li> <li> <p>Hospital length of stay (from hospital admission to hospital discharge or death)</p> </li> <li> <p>ICU length of stay (from ICU admission to ICU discharge or death)</p> </li> <li> <p>Vital signs: blood pressure one hour post‐intervention, respiratory rate</p> </li> <li> <p>Arterial blood gases (PaO<sub>2</sub>) one hour post‐intervention </p> </li> <li> <p>Adverse events</p> </li> </ul> </p> <p>For inclusion, studies had to report one or more of the clinical outcomes of interest. We sought additional information from principal investigators as required, including for outcomes that were measured but not reported in the final publication. </p> </section> </section> </section> <section id="CD005351-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005351-sec-0052"> <h4 class="title">Electronic searches</h4> <p>We identified trials through systematic searches of the following databases:</p> <p> <ul id="CD005351-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (CRS Web, 20 September 2018).</p> </li> <li> <p>Database of Abstracts of Reviews Effectiveness (DARE) in the Cochrane Library (Issue 2 of 4, 2015). </p> </li> <li> <p>MEDLINE (Ovid, 1946 to 19 September 2018).</p> </li> <li> <p>Embase (Ovid, 1974 to 19 September 2018).</p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL) Plus (EBSCO, 1937 to 20 September 2018). </p> </li> <li> <p>LILACS (1982 to 20 September 2018).</p> </li> <li> <p>WHO International Clinical Trials Registry Platform (ICTRP; <a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>) (searched 20 September 2018). </p> </li> <li> <p><a href="http://Clinicaltrials.gov" target="_blank">Clinicaltrials.gov</a> (searched 20 September 2018) </p> </li> </ul> </p> <p>The RCT filter for MEDLINE is the Cochrane sensitivity‐maximising RCT filter and, for Embase search terms as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> were applied. (<a href="./references#CD005351-bbs2-0084" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Lefebvre 2011</a>). We searched all databases from their inception to the present, without language restriction or consideration of final publication status. We present the search strategies for each database in <a href="./appendices#CD005351-sec-0109">Appendix 1</a>. Finally, we also considered studies that were ongoing or awaiting classification at the time of the last version of this review. </p> </section> <section id="CD005351-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We checked the bibliographies of retrieved articles to identify related published and unpublished studies. </p> </section> </section> <section id="CD005351-sec-0054"> <h3 class="title" id="CD005351-sec-0054">Data collection and analysis</h3> <p>We followed the recommendations outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> in preparing this review (<a href="./references#CD005351-bbs2-0079" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>; <a href="./references#CD005351-bbs2-0080" title="HigginsJP , ChurchillR , ChandlerJ , CumpstonMS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook2017. ">Higgins 2017</a>). </p> <section id="CD005351-sec-0055"> <h4 class="title">Selection of studies</h4> <p>In our updated search, two review authors (NB, MC) independently screened citations and selected trials that met the inclusion criteria. We resolved disagreements by consensus with a third review author (YW). In the previous version of this review, two review authors (FV and ML) independently screened citations and selected trials meeting the inclusion criteria with disagreements resolved by a third review author (AA) (<a href="./references#CD005351-bbs2-0110" title="VitalFMR , LadeiraMT , AtallahÁN . Non‐invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD005351.pub3] ">Vital 2013</a>). </p> </section> <section id="CD005351-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>We used a standardised and piloted data collection form to record data on study characteristics, risks of bias, and outcomes. Two review authors (NB, YW) independently extracted: </p> <p> <ul id="CD005351-list-0004"> <li> <p>characteristics of the study (design, methods of randomisation, withdrawals and dropouts, intention‐to‐treat analysis (ITT), informed consent, place and multicentre study, funding, conflicts of interest, study dates); </p> </li> <li> <p>participants (age, gender, number, diagnostic criteria, inclusion and exclusion criteria);</p> </li> <li> <p>interventions (type of NPPV, timing and duration of therapy, co‐interventions, SMC (intervention and dose); and </p> </li> <li> <p>outcomes reported.</p> </li> </ul> </p> <p>We requested unpublished data from primary authors to supplement outcomes where needed. Two review authors (NB, YW) performed data extraction for all selected study reports independently, with partial extraction by an additional two review authors (CG and MA). We resolved disagreements by consensus with a third senior review author (MC). </p> </section> <section id="CD005351-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (NB, YW) independently assessed risks of bias for each study, using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005351-bbs2-0079" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). We resolved any disagreements by consensus with a third review author (MC). We assessed risks of bias according to the following domains, using the Cochrane 'Risk of bias' tool: </p> <p> <ul id="CD005351-list-0005"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Completeness of outcome data.</p> </li> <li> <p>Selective reporting bias.</p> </li> <li> <p>Other bias (any other sources of potential bias, e.g. trial prematurely stopped)</p> </li> </ul> </p> <p>We graded each potential source of bias as high, low, or unclear and provide a justification for our judgement in the 'Risk of bias' table. We summarise the 'Risk of bias' judgements across different studies for each of the domains listed. If unpublished data were used in the 'Risk of bias' assessment, we noted this in the 'Risk of bias' table. When we considered treatment effects, we took into account the risks of bias for studies that contributed to that outcome. </p> <p><b>Assessment of bias in conducting the systematic review</b><br/> We conducted the review according to our published protocol and report any deviations from it in the <a href="#CD005351-sec-0117">Differences between protocol and review</a> section of the review. </p> </section> <section id="CD005351-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous data as risk ratios (RRs) with 95% confidence intervals (CIs), and continuous data as mean difference (MDs) with 95% CIs. </p> </section> <section id="CD005351-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>We included RCTs with a parallel design. If the same outcome was measured at repeated time points, we selected the longest time point for inclusion in the review, to avoid double counting. In trials with multiple intervention arms, we included the control group with SMC and combined the treatment groups if they had a similar intervention (NPPV: CPAP or BiPAP). For subgroup analysis in studies comparing CPAP, bilevel NPPV, and SMC we divided the control group evenly between groups, as suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005351-bbs2-0079" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD005351-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators or study sponsors to obtain missing numerical outcome data where required (e.g. when a study was reported as an abstract only). Where this was not possible and the missing data were thought to introduce serious bias, we explored the impact of study inclusion in the overall assessment of results by performing a sensitivity analysis. </p> </section> <section id="CD005351-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>We quantified the impact of statistical heterogeneity using the I<sup>2</sup> statistic (<a href="./references#CD005351-bbs2-0079" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). An I<sup>2</sup> of 0 to 40% may represent low heterogeneity, 30% to 60% may represent moderate heterogeneity, 50% to 90% may represent substantial heterogeneity, and 75% to 100% may represent considerable heterogeneity. In interpreting the heterogeneity values, we also considered the magnitude and direction of effects and strength of evidence for heterogeneity (e.g. P value from the Chi<sup>2</sup> test or a confidence interval for I<sup>2</sup>). In addition, we inspected forest plots for signs of heterogeneity. If substantial heterogeneity was present, we reported it and conducted exploratory analyses to identify sources of heterogeneity (e.g. participants, treatments and study quality). We hypothesised that age, gender, and co‐morbidities may represent potential sources of heterogeneity among participants. Furthermore, heterogeneity may be related to the initial treatment(s) used, the levels of pressure applied with NPPV, or treatment duration. </p> </section> <section id="CD005351-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>Funnel plots allowed us to examine and explore small‐study biases and publication bias (<a href="./references#CD005351-bbs2-0074" title="EggerM , SmithGD , SchneiderM , MinderC . Bias in meta‐analysis detected by simple, graph test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>). We generated funnel plots for each outcome with at least 10 studies. </p> </section> <section id="CD005351-sec-0063"> <h4 class="title">Data synthesis</h4> <p>We undertook meta‐analysis only where studies were sufficiently similar for results to be clinically meaningful and if we identified more than two trials reporting data for that outcome. For these studies, we pooled dichotomous and continuous variables using a random‐effects model. We chose a random‐effects model, as we anticipated heterogeneity in study participants, interventions, and outcomes of included studies. We presented the number needed to treat for an additional beneficial outcome (NNTB) when an effect was indicated by meta‐analysis. We report summary estimates of treatment effect with their associated 95% CIs. We conducted all analyses using Cochrane statistical software (<a href="./references#CD005351-bbs2-0097" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> <section id="CD005351-sec-0064"> <h5 class="title">'Summary of findings' table</h5> <p>We created a 'Summary of findings' table for the main outcomes of the review: hospital mortality, endotracheal intubation (ETI), acute myocardial infarction (AMI), intolerance to allocated treatment, hospital length of stay, ICU length of stay, and adverse events. We generated these tables using GRADEpro software (<a href="https://gradepro.org/" target="_blank">gradepro.org/</a>) and imported them into Review Manager 5. </p> </section> <section id="CD005351-sec-0065"> <h5 class="title">GRADE</h5> <p>We used the five GRADE domains (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it relates to the studies. For this process, we used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005351-bbs2-0079" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>; <a href="./references#CD005351-bbs2-0080" title="HigginsJP , ChurchillR , ChandlerJ , CumpstonMS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook2017. ">Higgins 2017</a>). We justified all decisions to downgrade the quality of evidence using footnotes provided in the 'Summary of findings' table (<a href="./references#CD005351-bbs2-0077" title="GuyattGH , OxmanAD , VistG , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. [DOI: 10.1136/bmj.39489.470347.AD] ">Guyatt 2008</a>; <a href="./references#CD005351-bbs2-0079" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). </p> <p>Two review authors (NB, YW) working independently, made judgements about evidence quality, with disagreements resolved by consensus with a third senior review author (MC). </p> </section> </section> <section id="CD005351-sec-0066"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed subgroup analyses for the following outcomes: hospital mortality, ETI, AMI, intolerance to allocated treatment, and hospital length of stay. Subgroups of interest included: type of NPPV (CPAP or bilevel NPPV), location of therapy (ER versus ICU), baseline hypercapnia status. In addition, for AMI we planned a subgroup analysis by time of event relative to treatment (AMI before or after initiation of treatment). Unfortunately, our planned AMI subgroup analysis was not possible, due to inconsistent definitions of AMI between studies. Please see <a href="#CD005351-sec-0117">Differences between protocol and review</a> for further details. For mean, systolic, and diastolic blood pressure after one hour of therapy we performed a subgroup analysis by NPPV type (CPAP or bilevel NPPV). We used the test for subgroup differences to detect whether the effect estimate differed between groups of studies. We used a P value of less than 0.05 for this test, as suggesting a true difference between subgroups, but acknowledge that this test has limited power when there are few studies. </p> </section> <section id="CD005351-sec-0067"> <h4 class="title">Sensitivity analysis</h4> <p>We decided a priori to perform sensitivity analyses on hospital mortality, ETI, and adverse events. These sensitivity analyses covered: </p> <p> <ul id="CD005351-list-0006"> <li> <p>including studies with only low risk of bias.</p> </li> <li> <p>including studies without missing data.</p> </li> <li> <p>including only studies with a final diagnosis of cardiogenic pulmonary oedema being present in 50% or more of included participants. </p> </li> </ul> </p> <p>For mortality, we considered a trial to be at low risk of bias if it met the criteria for low risk of bias in the following domains: random sequence generation and incomplete outcome data. For ETI and adverse events, we rated trials at low risk of bias if they met the low‐risk‐of‐bias criteria for the following domains: random sequence generation and allocation concealment. </p> <section id="CD005351-sec-0068"> <h5 class="title">Reaching conclusions</h5> <p>We base our conclusions only on findings from the quantitative or narrative synthesis of studies included in this review. In addition, we outline the gaps in the evidence for NPPV in ACPE, and suggest future directions for research. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005351-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005351-sec-0069"></div> <section id="CD005351-sec-0070"> <h3 class="title">Description of studies</h3> <section id="CD005351-sec-0071"> <h4 class="title">Results of the search</h4> <p>Our updated search identified 3791 references (CENTRAL 905, DARE 12, MEDLINE 1266, Embase 878, LILACS 67, CINAHL Plus 397, WHO ICTRP 168, and <a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a> 98). After de‐duplication and reviewing reference lists from included articles, we screened 2807 references for inclusion. After screening, we obtained full‐text articles for 94 references. UItimately, we have included in this review update 24 studies (37 references) with a total of 2664 participants treated with NPPV versus SMC for ACPE. We excluded 43 studies (57 references). Our review update includes seven new studies since May 2013 (<a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>) and excludes 15 previously included studies (<a href="./references#CD005351-bbs2-0028" title="BautinA , KhubulavaG , NaumovA , GarifzjanovA , EtinV . NPPV in the treatment of the cardiogenic edema (CPE) after heart surgery. European Respiratory Journal2005;26(Suppl 49):3112. ">Bautin 2005;</a><a href="./references#CD005351-bbs2-0031" title="BelloneA , MonariA , CortellaroF , VetorelloM , ArlatiS , CoenD . Myocardial infarction rate in acute pulmonary edema: noninvasive support ventilation versus continuous positive airway pressure. Critical Care Medicine2004;32(9):1860‐5. ">Bellone 2004</a>; <a href="./references#CD005351-bbs2-0032" title="BelloneA , VettorelloM , MonariA , CortellaroF , CoenD . Noninvasive pressure support ventilation vs. continuous positive airway pressure in acute hypercapnic pulmonary edema. Intensive Care Medicine2005;31:807‐11. ">Bellone 2005</a>; <a href="./references#CD005351-bbs2-0034" title="BerstenAD , HoltAW , VedigAE , SkowronskiGA , BagooleyCJ . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. New England Journal of Medicine1991;325(26):1825‐30. ">Bersten 1991</a>; <a href="./references#CD005351-bbs2-0038" title="DelclauxC , L'HerE , AlbertiC , ManceboJ , AbrougF , ContiG , et al. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivery by a face mask. JAMA2000;284:2352‐60. ">Delclaux 2000</a>; <a href="./references#CD005351-bbs2-0042" title="FerrerM , EsquinasA , LeonM , GonzalezG , AlarconA , TorresA . Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. American Journal of Respiratory and Critical Care Medicine2003;168(12):1438‐44. ">Ferrer 2003</a>; <a href="./references#CD005351-bbs2-0040" title="FerrariG , OlliveriF , DeFilippiG , MilanA , ApraF , BoccuzziA , et al. Noninvasive positive airway pressure and risk of myocardial infarction in acute cardiogenic pulmonary edema: continuous positive airway pressure vs noninvasive positive pressure ventilation. Chest2007;132(6):1804‐9. ">Ferrari 2007</a>; <a href="./references#CD005351-bbs2-0041" title="FerrariG , GroffP , DeFilippiG , GiostraF , MazzoneM , PotaleG , et al. Continuous positive airway pressure (CPAP) vs. noninvasive positive pressure ventilation (NIV) in acute cardiogenic pulmonary edema (ACPE): A prospective randomized multicentric study. Journal of Emergency Medicine2006;30:246‐7. FerrariG , MilanA , GroffP , PagnozziF , MazzoneM , MolinoP , et al. Continuous positive airway pressure vs. pressure support ventilation in acute cardiogenic pulmonary edema: a randomized trial. Journal of Emergency Medicine2010;39(5):676‐84. NCT00446498 . CPAP Versus NPPV in ACPE [Continuous positive airway pressure versus non‐invasive positive pressure support ventilation in acute cardiogenic pulmonary oedema: a prospective randomised multicentre trial]. clinicaltrials.gov/show/nct00446498 (first received 13 March 2007). ">Ferrari 2010</a>; <a href="./references#CD005351-bbs2-0043" title="BordonaliT , FontanellaB , AffatatoA , SaporettiA , CarubelliV , CiccareseC , et al. Comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (NIPSV) in acute cardiogenic pulmonary edema. European Heart Journal2009;30:369. [EMBASE: 797] FontanellaB , AffatatoA , CiccareseC , SacchiniM , VolpiniM , BianchettiF , et al. Prospective comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (BPAP) in acute cardiogenic pulmonary edema. European Heart Journal Supplements2010;12 (supplement F):F37‐F38. ">Fontanella 2010</a>; <a href="./references#CD005351-bbs2-0049" title="LieschingT , NelsonDL , CormierKL , SucovA , ShortK , WarburtonR , et al. Randomized trial of bilevel versus continuous positive airway pressure for acute pulmonary edema. Journal of Emergency Medicine2014;46(1):130‐40. [PUBMED: 24071031] LieschingTN , CromierK , NelsonD , ShortK , SucovA , HillNS . Bilevel noninvasive ventilation vs continuous positive airway pressure to treat acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;167(Suppl 7):27. ">Liesching 2014</a>; <a href="./references#CD005351-bbs2-0050" title="Martin‐BermudezR , Rodríguez‐PortalJ , García‐GarmendiaJ . Non‐invasive ventilation in cardiogenic pulmonary edema. Preliminary results of a randomized trial. Intensive Care Medicine2002;28:S68. ">Martin‐Bermudez 2002</a>; <a href="./references#CD005351-bbs2-0051" title="MehtaS , JayGD , WoolardRH , HiponaRA , ConnollyEM , CiminiDM , et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Critical Care Medicine1997;25(4):620‐8. ">Mehta 1997</a>; <a href="./references#CD005351-bbs2-0053" title="MoritzF , BrousseB , GelleeB , ChajaraA , L'HerE , HellotMF , et al. Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial. Annals of Emergency Medicine2007;50(6):666‐75. [PUBMED: 17764785] ">Moritz 2007</a>; <a href="./references#CD005351-bbs2-0063" title="SharonA , ShpirerI , KaluskiE , MoshkovitzY , MilanovO , PolakR , et al. High‐dose intravenous Isosorbide‐dinitrate is safer and better than Bi‐PAP ventilation for severe pulmonary edema. Journal of the American College of Cardiology2000;36(3):832‐7. [PUBMED: 10987607] ">Sharon 2000</a>; <a href="./references#CD005351-bbs2-0067" title="WeitzG , StruckJ , ZonakA , BalnusS , PerrasB , DodtC . Prehospital noninvasive pressure support ventilation for acute cardiogenic pulmonary edema. European Journal of Emergency Medicine2007;14(5):276‐9. ">Weitz 2007</a>). Our PRISMA flowchart summarises the study selection process (<a href="#CD005351-fig-0001">Figure 1</a>). We provide additional information on included and excluded studies in the following sections: <a href="./references#CD005351-sec-0120" title="">Characteristics of included studies</a>; <a href="./references#CD005351-sec-0121" title="">Characteristics of excluded studies</a>. </p> <div class="figure" id="CD005351-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA statement flow diagram for 2019 review update." data-id="CD005351-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA statement flow diagram for 2019 review update.</p> </div> </div> </div> </section> <section id="CD005351-sec-0072"> <h4 class="title">Included studies</h4> <section id="CD005351-sec-0073"> <h5 class="title">Study design</h5> <p>We included 24 parallel‐design RCTs in this review update (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>). The funding sources for seven studies was public (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>). One study reported receiving funds from a nonprofit organisation (<a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>). Two studies were funded by device manufacturers (<a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>) and 14 studies provided no details on funding sources (<a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>). We summarise each study in our <a href="./references#CD005351-sec-0120" title="">Characteristics of included studies</a> tables. </p> </section> <section id="CD005351-sec-0074"> <h5 class="title">Population</h5> <p>The mean participant age in our review was 73.3 ± 9.0 years. Our review includes studies from 14 countries: Australia, Belgium, Brazil, China, Egypt, Finland, France, Iran, Italy, Japan, Spain, Taiwan, the UK, and the USA. Furthermore, five studies were multicentre (<a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>). Studies varied in size from eight to 1069 participants, with a median and mean study size of 55 and 114 participants respectively. Ten studies were conducted in an emergency department (ED or ER) setting (<a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>), eight studies were conducted in an ICU setting (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>), and three studies did not reference a specific study location (<a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>). Three studies were started in the pre‐hospital setting with further care in the ER and the ICU if required (<a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>). </p> </section> <section id="CD005351-sec-0075"> <h5 class="title">Intervention</h5> <p>Six studies compared all three interventions: CPAP, bilevel NPPV, and SMC (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>). Twelve studies compared CPAP against SMC (<a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>). Six studies compared bilevel NPPV against SMC (<a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>). We summarise the NPPV settings including mask type, inspiratory positive airway pressure (IPAP), expiratory positive airway pressure (EPAP), positive end‐expiratory pressure (PEEP), and duration of NPPV in <a href="#CD005351-tbl-0002">Table 1</a>. The NPPV patient‐ventilator interface varied between exclusive use of nasal masks (<a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>), a choice between a nasal or face mask (<a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>), and exclusive use of face masks. We have summarised the SMC provided in each trial in <a href="#CD005351-tbl-0003">Table 2</a>. SMC included supplemental oxygen and pharmacologic treatments. SMC pharmacologic treatments included loop diuretics (furosemide), nitrates (e.g. nitroglycerin, isosorbide dinitrate), opioids (e.g. morphine), and ionotropes if required. </p> <div class="table" id="CD005351-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">NPPV intervention summary: EPAP, IPAP, and PEEP settings, duration of therapy.</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mask type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>IPAP level (cmH2O) ± SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EPAP in bilevel NPPV (cmH2O) ± SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PEEP in CPAP (cmH2O) ± SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time of bilevel NPPV (h) ± SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time of CPAP (h) ± SD</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). "><b>Agmy 2008</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. "><b>Austin 2013</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.583333</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. "><b>Crane 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). "><b>Ducros 2011</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] "><b>El‐Refay 2016</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. "><b>Frontin 2011</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). "><b>Gray 2008</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14±5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 ± 3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 ± 4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 ± 1.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.2 ± 1.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. "><b>Hao 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.6 ± 2.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. "><b>Kelly 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. "><b>L'Her 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. "><b>Levitt 2001</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask selected for mouth breathers Nasal available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. "><b>Li 2005</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 to 18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 to 8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. "><b>Lin 1991</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. "><b>Lin 1995</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. "><b>Masip 2000</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.2 ± 2.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2 ± 1.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] "><b>Moritz 2003</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.3 ± 0.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] "><b>Nava 2003</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.5 ± 21.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.1 ± 3.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.4 ± 3.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] "><b>Park 2001</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nasal bilevel and face mask for CPAP</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.6 ± 0.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.8 ± 1.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] "><b>Park 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17 ± 2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 ± 2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 ± 2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.1 ± 1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.7 ± 0.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] "><b>Räsänen 1985</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] "><b>Takeda 1997</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nasal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.9 ± 8.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] "><b>Takeda 1998</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nasal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] "><b>Thys 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.5 ± 3.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.1 ± 1.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.3 ± 0.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] "><b>Zokaei 2016</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask 1st, nasal 2nd</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 to 20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Not all papers provided a mean and standard deviation. Where unavailable, the range represents the IPAP/EPAP/CPAP settings described in the Methods. NA: not applicable </p> </div> </div> <div class="table" id="CD005351-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Standard medical therapy for each trial</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lasix</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lasix dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nitrate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FiO<sub>2</sub> mask and %FiO<sub>2</sub> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Other</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Additional differences between SMC received in treatment group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). "><b>Agmy 2008</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. "><b>Austin 2013</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual 400 ‐ 1600 mcg q5min</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, 8 ‐ 15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 1 ‐ 2 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. "><b>Crane 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitrates</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, 10 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>diamorphine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). "><b>Ducros 2011</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lasix 40 mg ‐ 120 mg IV or 1 ‐ 3 mg bumetanide</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin (1 mg per 3 min) and a continuous IV infusion unless systolic BP &lt; 110 mmHg </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] "><b>El‐Refay 2016</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lasix 40 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin 0.4 mg sublingual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 2 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. "><b>Frontin 2011</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mg/kg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>isosorbide dinitrate IV 2 mg if SBP &gt; 180 mmHg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). "><b>Gray 2008</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 mg above usual dose to max 100 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal nitrates 2 ‐ 5 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opiates</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. "><b>Hao 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 ‐ 40 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal nitrates 0.5 mg to 1 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 2 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. "><b>Kelly 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 ‐ 100 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>buccal nitrate 5 mg if systolic BP &gt; 90 mmHg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>oxygen 60% by venturi mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>morphine IV 2.5 ‐ 10 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. "><b>Li 2005</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mask high concentration</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. "><b>Levitt 2001</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mask high flow</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. "><b>L'Her 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin IV infusion 1 mg/hour</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 2 ‐ 10 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. "><b>Lin 1991</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 100% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. "><b>Lin 1995</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg IV or double home dose</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin sublingual 0.6 mg or isosorbide 10 ‐ 20 mg, or nitro infusion 10 ‐ 50 mcg/min </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 100% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 2 ‐ 10 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. "><b>Masip 2000</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV glyceryl trinitrate 1mg if systolic BP &gt; 180 mmHg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 50% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 4 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] "><b>Moritz 2003</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg IV or double home dose</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV nitroglycerin infusion 0.125 ‐ 0.25 mcg/kg/min</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 100% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] "><b>Nava 2003</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg IV or double usual dose, repeated, if necessary, every 20 mins, up to 320 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>continuous glyceryl trinitrate at an initial rate of 1.5 mg/hour. A bolus dose of 1 mg IV was added if systolic BP &gt; 180 mmHg </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>morphine sulphate up to 4 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] "><b>Park 2001</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 mg isosorbide dinitrite if systolic BP &gt; 100 mm Hg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] "><b>Park 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 mg isosorbide dinitrate was given sublingually and if necessary titrated up to 15 mg </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 50% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] "><b>Räsänen 1985</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 ‐ 80 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroprusside, nitroglycerine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 30% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] "><b>Takeda 1997</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroglycerin infusion</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO2 50%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] "><b>Takeda 1998</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroglycerin infusion</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 70% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] "><b>Thys 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>isosorbide dinitrate 2 mg/hour</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] "><b>Zokaei 2016</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 ‐ 320 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV nitroglycerin 5 ‐ 50 mcg/kg/min</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>morphine 5 ‐ 10 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BP: blood pressure; FiO<sub>2</sub>: fraction of inspired oxygen; IV: intravenous; Lpm: litres per minute; NA: not available; mcg: micrograms; mcg/kg/min: micrograms per kilogram per minute; mg: milligrams; min: minutes; mmHg = millimetres of mercury </p> </div> </div> </section> <section id="CD005351-sec-0076"> <h5 class="title">Outcomes</h5> <p>Commonly‐reported outcomes included hospital mortality, endotracheal intubation (ETI), acute myocardial infarction (AMI), hospital length of stay, ICU length of stay, change in systolic blood pressure (SBP) and respiratory rate (RR) during treatment, and change in arterial blood glasses (PaO<sub>2</sub>). In reviewing the methodology for each study, we found that only three studies (<a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>) provided a power calculation to detect a mortality difference. In addition, hospital mortality was reported at variable time periods. We summarise the time point at which hospital mortality was measured in <a href="#CD005351-tbl-0004">Table 3</a>. The median length of follow‐up for hospital mortality was 13 days. AMI during the study period was reported by five studies (<a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>). AMI definitions were inconsistent, varying between new ST segment elevation on ECG, to myocardial enzyme elevation (e.g. CK, troponin) with ECG changes, and myocardial enzyme elevation alone. Treatment intolerance or early treatment discontinuation was reported by <a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>. Explicit definitions for treatment failure as an indicator for potential endotracheal intubation are summarised in <a href="#CD005351-tbl-0005">Table 4</a>. </p> <div class="table" id="CD005351-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">In‐hospital mortality duration of follow‐up</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up (days)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). "><b>Agmy 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. "><b>Austin 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. "><b>Crane 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). "><b>Ducros 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] "><b>El‐Refay 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. "><b>Frontin 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). "><b>Gray 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. "><b>Hao 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. "><b>Kelly 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. "><b>Li 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. "><b>Levitt 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. "><b>L'Her 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. "><b>Lin 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. "><b>Lin 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. "><b>Masip 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] "><b>Moritz 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] "><b>Nava 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] "><b>Park 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] "><b>Park 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] "><b>Räsänen 1985</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] "><b>Takeda 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] "><b>Takeda 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] "><b>Thys 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.6<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] "><b>Zokaei 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Estimated based on longest reported mean hospital length of stay; <sup>b</sup>Based on latest death reported in trial </p> </div> </div> <div class="table" id="CD005351-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Intubation criteria for trials reporting endotracheal intubation rates</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intubation Criteria</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). "><b>Agmy 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. "><b>Austin 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. "><b>Crane 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR &gt; 40, RR &lt; 10, altered level of consciousness, arterial pH &lt; 7.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). "><b>Ducros 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SpO<sub>2</sub> &lt; 85% after 30 mins of 15 Lpm or FiO<sub>2</sub> 60% CPAP, respiratory arrest, psychomotor agitation, SBP &lt; 80 mmHg </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] "><b>El‐Refay 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. "><b>Frontin 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Worsening SpO<sub>2</sub> despite effective treatment, loss of airway protective reflexes (cough, swallow), decreased level of consciousness, haemodynamic instability, intolerance/poor fit of face mask for the CPAP group, medical clinical impression of deterioration, or participant request </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). "><b>Gray 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At discretion of treating clinician</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. "><b>L'Her 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiac or respiratory arrest, severe haemodynamic instability (SBP &lt; 80), administration of epinephrine/norepinephrine, refractory hypoxaemia SaO<sub>2</sub> &lt; 92% despite face mask, clinical signs of respiratory exhaustion (accessory muscle use with paradoxical abdominal motion), coma or seizures, agitation requiring sedation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. "><b>Levitt 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical or arterial blood gas findings. Severe respiratory distress, deterioration in mental status, or further deterioration in vital signs with increasing HR, RR, or a decrease in BP. Decrease in pO<sub>2</sub> &lt; 60 or rise in pCO<sub>2</sub> &gt; 50 along with signs of clinical deterioration warranted intubation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. "><b>Lin 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinician discretion. Loss of consciousness or airway obstruction were indications for intubation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. "><b>Lin 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiopulmonary resuscitation or clinical deterioration with any 2 of the following: (1) a rise in arterial carbon dioxide tension to more than 55 mm Hg; (2) arterial blood oxygen partial pressure divided by fraction of inspired oxygen content less than 200 mm Hg; and (3) respiratory rate over 35 breaths/min. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. "><b>Masip 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients were intubated when the criteria for treatment failure were met. Details not specified. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] "><b>Nava 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] "><b>Park 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical judgement</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] "><b>Park 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical judgement</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] "><b>Räsänen 1985</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical judgement. Loss of consciousness or airway obstruction were indications for intubation at any time. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] "><b>Takeda 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical deterioration and either a decrease in the PaO<sub>2</sub>/FiO<sub>2</sub> &lt; 100 with an FIO<sub>2</sub> ≥ 70% or a increase in the PaCO<sub>2</sub> &gt; 55 mmHg </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] "><b>Takeda 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical deterioration and either a fall in PaO<sub>2</sub>/FiO<sub>2</sub> &lt; 100 with an FiO<sub>2</sub> of 70% or a rise in PaCO<sub>2</sub> to &gt; 55 mmHg. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] "><b>Thys 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Deterioration in clinical status including all of the following: dyspnoea, respiratory or heart frequency or both, sweating and agitation or deterioration in blood gases or in haemodynamic status or both </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] "><b>Zokaei 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR after 1 hour of bilevel NPPV &gt; 30, persistent hypoxaemia, haemodynamic instability (systolic BP &lt; 70), agitation, or worsened neurologic status, inability to tolerate mask or aspiration of gastric content </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BP: blood pressure; CPAP: continuous positive airway pressure; FiO<sub>2</sub>: fraction of inspired oxygen; HR: heart rate; Lpm: litres per minute; PaCO<sub>2</sub>: arterial partial pressure of carbon dioxide; PaO<sub>2</sub>: arterial partial pressure of oxygen; RR: respiratory rate; SBP: systolic blood pressure </p> </div> </div> <p>Several outcomes, including systolic blood pressure, mean blood pressure, diastolic blood pressure, PaO<sub>2</sub>, and respiratory rate, are reported as continuous outcomes. For these outcomes, we used the reported mean and standard deviations. Certain data were only available in graphical format and we extracted them by measuring the graph: PaO<sub>2</sub> (<a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>). We converted arterial blood gas data from kilopascals (kPa) to millimetres of mercury (mmHg) for three studies (<a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>), using the conversion of 1 kPA to 7.50 mmHg (<a href="./references#CD005351-bbs2-0107" title="Zumdahl , SS . Chemical Principles. 4th Edition. Boston, MA: Houghton Mifflin Company, 2002. ">Zumdahl 2002</a>). </p> </section> </section> <section id="CD005351-sec-0077"> <h4 class="title">Excluded studies</h4> <p>We excluded citations if they were duplicates of the same study (N = 27), an ineligible intervention (N = 14), an ineligible population (N = 5), a quasi‐randomised controlled trial (N = 4), an ineligible study type (N = 17), and if the study was withdrawn after study registration (N = 3). We have excluded 15 studies included in the previous version of this review. Of these, we excluded three studies conducted on an inappropriate population (<a href="./references#CD005351-bbs2-0028" title="BautinA , KhubulavaG , NaumovA , GarifzjanovA , EtinV . NPPV in the treatment of the cardiogenic edema (CPE) after heart surgery. European Respiratory Journal2005;26(Suppl 49):3112. ">Bautin 2005</a>; <a href="./references#CD005351-bbs2-0038" title="DelclauxC , L'HerE , AlbertiC , ManceboJ , AbrougF , ContiG , et al. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivery by a face mask. JAMA2000;284:2352‐60. ">Delclaux 2000</a>; <a href="./references#CD005351-bbs2-0042" title="FerrerM , EsquinasA , LeonM , GonzalezG , AlarconA , TorresA . Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. American Journal of Respiratory and Critical Care Medicine2003;168(12):1438‐44. ">Ferrer 2003</a>). We excluded four quasi‐randomised controlled trials (<a href="./references#CD005351-bbs2-0034" title="BerstenAD , HoltAW , VedigAE , SkowronskiGA , BagooleyCJ . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. New England Journal of Medicine1991;325(26):1825‐30. ">Bersten 1991</a>; <a href="./references#CD005351-bbs2-0053" title="MoritzF , BrousseB , GelleeB , ChajaraA , L'HerE , HellotMF , et al. Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial. Annals of Emergency Medicine2007;50(6):666‐75. [PUBMED: 17764785] ">Moritz 2007</a>; <a href="./references#CD005351-bbs2-0063" title="SharonA , ShpirerI , KaluskiE , MoshkovitzY , MilanovO , PolakR , et al. High‐dose intravenous Isosorbide‐dinitrate is safer and better than Bi‐PAP ventilation for severe pulmonary edema. Journal of the American College of Cardiology2000;36(3):832‐7. [PUBMED: 10987607] ">Sharon 2000</a>; <a href="./references#CD005351-bbs2-0067" title="WeitzG , StruckJ , ZonakA , BalnusS , PerrasB , DodtC . Prehospital noninvasive pressure support ventilation for acute cardiogenic pulmonary edema. European Journal of Emergency Medicine2007;14(5):276‐9. ">Weitz 2007</a>). Finally, we excluded eight studies which compared bilevel NPPV against CPAP, without an additional comparison against SMC (<a href="./references#CD005351-bbs2-0031" title="BelloneA , MonariA , CortellaroF , VetorelloM , ArlatiS , CoenD . Myocardial infarction rate in acute pulmonary edema: noninvasive support ventilation versus continuous positive airway pressure. Critical Care Medicine2004;32(9):1860‐5. ">Bellone 2004</a>; <a href="./references#CD005351-bbs2-0032" title="BelloneA , VettorelloM , MonariA , CortellaroF , CoenD . Noninvasive pressure support ventilation vs. continuous positive airway pressure in acute hypercapnic pulmonary edema. Intensive Care Medicine2005;31:807‐11. ">Bellone 2005</a>; <a href="./references#CD005351-bbs2-0040" title="FerrariG , OlliveriF , DeFilippiG , MilanA , ApraF , BoccuzziA , et al. Noninvasive positive airway pressure and risk of myocardial infarction in acute cardiogenic pulmonary edema: continuous positive airway pressure vs noninvasive positive pressure ventilation. Chest2007;132(6):1804‐9. ">Ferrari 2007</a>; <a href="./references#CD005351-bbs2-0041" title="FerrariG , GroffP , DeFilippiG , GiostraF , MazzoneM , PotaleG , et al. Continuous positive airway pressure (CPAP) vs. noninvasive positive pressure ventilation (NIV) in acute cardiogenic pulmonary edema (ACPE): A prospective randomized multicentric study. Journal of Emergency Medicine2006;30:246‐7. FerrariG , MilanA , GroffP , PagnozziF , MazzoneM , MolinoP , et al. Continuous positive airway pressure vs. pressure support ventilation in acute cardiogenic pulmonary edema: a randomized trial. Journal of Emergency Medicine2010;39(5):676‐84. NCT00446498 . CPAP Versus NPPV in ACPE [Continuous positive airway pressure versus non‐invasive positive pressure support ventilation in acute cardiogenic pulmonary oedema: a prospective randomised multicentre trial]. clinicaltrials.gov/show/nct00446498 (first received 13 March 2007). ">Ferrari 2010</a>; <a href="./references#CD005351-bbs2-0043" title="BordonaliT , FontanellaB , AffatatoA , SaporettiA , CarubelliV , CiccareseC , et al. Comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (NIPSV) in acute cardiogenic pulmonary edema. European Heart Journal2009;30:369. [EMBASE: 797] FontanellaB , AffatatoA , CiccareseC , SacchiniM , VolpiniM , BianchettiF , et al. Prospective comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (BPAP) in acute cardiogenic pulmonary edema. European Heart Journal Supplements2010;12 (supplement F):F37‐F38. ">Fontanella 2010</a>; <a href="./references#CD005351-bbs2-0049" title="LieschingT , NelsonDL , CormierKL , SucovA , ShortK , WarburtonR , et al. Randomized trial of bilevel versus continuous positive airway pressure for acute pulmonary edema. Journal of Emergency Medicine2014;46(1):130‐40. [PUBMED: 24071031] LieschingTN , CromierK , NelsonD , ShortK , SucovA , HillNS . Bilevel noninvasive ventilation vs continuous positive airway pressure to treat acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;167(Suppl 7):27. ">Liesching 2014</a>; <a href="./references#CD005351-bbs2-0050" title="Martin‐BermudezR , Rodríguez‐PortalJ , García‐GarmendiaJ . Non‐invasive ventilation in cardiogenic pulmonary edema. Preliminary results of a randomized trial. Intensive Care Medicine2002;28:S68. ">Martin‐Bermudez 2002</a>; <a href="./references#CD005351-bbs2-0051" title="MehtaS , JayGD , WoolardRH , HiponaRA , ConnollyEM , CiminiDM , et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Critical Care Medicine1997;25(4):620‐8. ">Mehta 1997</a>). We provide additional details explaining each excluded study in <a href="./references#CD005351-sec-0121" title="">Characteristics of excluded studies</a> tables. </p> </section> </section> <section id="CD005351-sec-0078"> <h3 class="title">Risk of bias in included studies</h3> <p>We present our 'Risk of bias' assessments in <a href="./references#CD005351-sec-0120" title="">Characteristics of included studies</a> tables. We provide a graphic summary of our assessments (<a href="#CD005351-fig-0002">Figure 2</a>; <a href="#CD005351-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD005351-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005351-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD005351-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005351-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD005351-sec-0079"> <h4 class="title">Allocation</h4> <p>All included studies had randomly‐allocated treatments. Randomisation sequence generation was at low risk of bias in eight studies (<a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>) and at unclear risk of bias in 16 studies (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>). </p> <p>Allocation concealment was at low risk of bias in seven studies (<a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>), at unclear risk of bias in 16 studies (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>), and at high risk of bias in one study (<a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>). </p> </section> <section id="CD005351-sec-0080"> <h4 class="title">Blinding</h4> <p>Blinding of participants and personnel was not possible for most studies, given the nature of the intervention. Twelve studies were at unclear risk of bias, as they did not state whether or not they had blinded participants and personnel (<a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>). Twelve studies did not blind participants and personnel (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>). </p> <p>Blinding of outcome assessments was not explicitly stated for most studies. Three studies were at low risk of bias for outcome assessment blinding (<a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>), 19 studies were at unclear risk of bias (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>), and two studies were at high risk of bias (<a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>). </p> </section> <section id="CD005351-sec-0081"> <h4 class="title">Incomplete outcome data</h4> <p>Three studies had high risk of bias due to incomplete outcome data (<a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>). These studies excluded a significant number of participants after randomisation. Seven studies did not present enough information to judge the completeness of outcome data and were rated at unclear risk (<a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>). Fourteen studies presented complete outcome data and were at low risk of bias (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>). </p> </section> <section id="CD005351-sec-0082"> <h4 class="title">Selective reporting</h4> <p>Most studies did not provide enough information to judge whether they included all planned outcomes. Three studies (<a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>) were at low risk of bias for selective reporting, given that the authors performed prospective trial registration and reported all their prespecified outcomes. Eighteen studies did not present enough information to determine if the outcomes presented were prespecified, and were at unclear risk of bias (<a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>). Three studies were at high risk of bias, as they failed to report prespecified outcomes or the outcomes reported were not in an extractable format (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>). </p> </section> <section id="CD005351-sec-0083"> <h4 class="title">Other potential sources of bias</h4> <p>Two studies were reported in abstract form only (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>). Seven studies had high risk of other potential sources of bias (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. ">Levitt 2001</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>). <a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a> was reported as a personal communication in addition to abstracts which did not have quantitative data. There is a discrepancy between counts reported on <a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a> and the personal communication data. We have used the personal communication data in our analysis. Other potential sources of bias included study termination due to poor recruitment, low likelihood of significant findings, or presenting data without a measure of variance (e.g. standard deviation). Our funnel plot of hospital mortality for NPPV versus SMC demonstrates some asymmetry for studies of intermediate sample size, which may indicate the presence of publication bias (see <a href="#CD005351-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD005351-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.1 HOSPITAL MORTALITY." data-id="CD005351-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.1 HOSPITAL MORTALITY.</p> </div> </div> </div> </section> </section> <section id="CD005351-sec-0084"> <h3 class="title" id="CD005351-sec-0084">Effects of interventions</h3> <p>See: <a href="./full#CD005351-tbl-0001"><b>Summary of findings for the main comparison</b> NPPV compared to SMC for cardiogenic pulmonary oedema</a> </p> <section id="CD005351-sec-0085"> <h4 class="title">Hospital mortality</h4> <p>NPPV may reduce hospital mortality compared to SMC alone (RR 0.65, 95% CI 0.51 to 0.82; participants = 2484; studies = 21; I<sup>2</sup> = 6%; <a href="./references#CD005351-fig-0007" title="">Analysis 1.1</a>; low quality of evidence), with a number needed to treat for an additional beneficial outcome (NNTB) of 17 (NNTB 12 to NNTB 32). We summarise our findings in <a href="./full#CD005351-tbl-0001">summary of findings Table for the main comparison</a>. We downgraded the evidence for hospital mortality by one level due to serious risk of bias (unclear or high risk of bias for randomisation sequence, allocation concealment, and other significant bias), and by one level due to imprecision (most trials had few participants and events, with a wide confidence interval). </p> <p>We performed subgroup analysis by NPPV type (CPAP or bilevel), and found no significant difference between CPAP or bilevel NPPV (<a href="./references#CD005351-fig-0008" title="">Analysis 1.2</a>), based on the test for differences between subgroups (P = 0.64). <a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a> reported no deaths in the bilevel NPPV arm and the SMC arm. <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a> reported no deaths in the CPAP or bilevel NPPV arms. CPAP may reduce hospital mortality (RR 0.65, 95% CI 0.48 to 0.88; participants = 1454; studies = 16; I<sup>2</sup> = 9%) and bilevel NPPV may reduce hospital mortality (RR 0.72, 95% CI 0.53 to 0.98; participants = 1030; studies = 11; I<sup>2</sup> = 0%). </p> <p>Our treatment location subgroup analysis (<a href="./references#CD005351-fig-0009" title="">Analysis 1.3</a>) revealed no significant difference between participants treated with NPPV in the ER compared to the ICU, based on the test for differences between subgroups (P = 0.51). People treated with NPPV in the ICU may have reduced hospital mortality compared to SMC (RR 0.52, 95% CI 0.35 to 0.77; participants = 862; studies = 10; I<sup>2</sup> = 0%). Similarly, people treated with NPPV in the ER may have reduced hospital mortality compared to SMC (RR 0.66, 95% CI 0.47 to 0.93; participants = 1596; studies = 10; I<sup>2</sup> = 18%). Baseline PaCO<sub>2</sub> subgroup analysis (<a href="./references#CD005351-fig-0010" title="">Analysis 1.4</a>) revealed a significant subgroup difference between studies with baseline eucapnia or hypercapnia (test for differences between subgroups P = 0.005). People with eucapnia treated with NPPV compared to SMC may have reduced hospital mortality (RR 0.41, 95% CI 0.27 to 0.63; participants = 581; studies = 10; I<sup>2</sup> = 0%). In contrast, hypercapnic people may not benefit from NPPV compared to SMC (RR 0.82, 95% CI 0.65 to 1.03; participants = 1903; studies = 11; I<sup>2</sup> = 0%). </p> <p>Low‐risk‐of‐bias sensitivity analysis eliminated the observed reduction in hospital mortality with NPPV compared to SMC (RR 0.81, 95% CI 0.61 to 1.06; participants = 1505; studies = 7; <a href="./references#CD005351-fig-0011" title="">Analysis 1.5</a>; I<sup>2</sup> = 6%). A sensitivity analysis that excluded studies with missing data (RR 0.68, 95% CI 0.54 to 0.86; participants = 2283; studies = 18; <a href="./references#CD005351-fig-0012" title="">Analysis 1.6</a>; I<sup>2</sup> = 5%) indicates that NPPV may reduce hospital mortality. Finally, changing our statistical model from random‐effects to fixed‐effect also indicates that NPPV may reduce hospital mortality compared to SMC alone (RR 0.67, 95% CI 0.55 to 0.81; participants = 2484; studies = 21; <a href="./references#CD005351-fig-0013" title="">Analysis 1.7</a>; I<sup>2</sup> = 6%). </p> </section> <section id="CD005351-sec-0086"> <h4 class="title">Endotracheal intubation (ETI)</h4> <p>NPPV compared to SMC probably reduces ETI (RR 0.49, 95% CI 0.38 to 0.62; participants = 2449; studies = 20; <a href="./references#CD005351-fig-0014" title="">Analysis 1.8</a>; I<sup>2</sup> = 0%; moderate quality of evidence) with a NNTB of 13 (NNTB 11 to NNTB 18). Two studies contributed data from only one of their three study arms: <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a> reported no ETI events for CPAP or SMC arms, and <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a> reported no ETI events for CPAP or bilevel NPPV. </p> <p>Our subgroup analysis by NPPV type indicates no significant difference between CPAP or bilevel NPPV compared to SMC (test for differences between subgroups P = 0.75). Both CPAP compared to SMC (RR 0.46, 95% CI 0.34 to 0.62; participants = 1413; studies = 15; I<sup>2</sup> = 0%) and bilevel NPPV compared to SMC (RR 0.50, 95% CI 0.31 to 0.81; participants = 1036; studies = 11; I<sup>2</sup> = 23%) probably reduce ETI (<a href="./references#CD005351-fig-0015" title="">Analysis 1.9</a>). Treatment location subgroup analysis (ER or ICU, <a href="./references#CD005351-fig-0016" title="">Analysis 1.10</a>) revealed no significant difference between participants treated in the ER or ICU with NPPV compared to SMC (test for differences between subgroups P = 0.40). NPPV use in the ER setting probably reduces ETI (RR 0.60, 95% CI 0.37 to 0.96; participants = 1561; studies = 9; I<sup>2</sup> = 21%). Participants treated with NPPV in the ICU setting probably have reduced ETI (RR 0.40, 95% CI 0.29 to 0.56; participants = 862; studies = 10; I<sup>2</sup> = 0%). Our PaCO<sub>2</sub> subgroup analysis (<a href="./references#CD005351-fig-0017" title="">Analysis 1.11</a>) revealed a significant difference between baseline eucapnic and hypercapnic studies (test for differences between subgroups P = 0.03). Both eucapnic participants treated with NPPV (RR 0.37, 95% CI 0.26 to 0.52; participants = 523; studies = 9; I<sup>2</sup> = 0%) and hypercapnic participants treated with NPPV (RR 0.64, 95% CI 0.46 to 0.91; participants = 1926; studies = 11; I<sup>2</sup> = 0%) probably have reduced ETI rates compared to SMC, but the effect was larger in those with PaCO<sub>2</sub> ≤ 45 mmHg. </p> <p>Low‐risk‐of‐bias sensitivity analysis indicates there was probably no ETI rate reduction with NPPV compared to SMC (RR 0.85, 95% CI 0.55 to 1.32; participants = 1491; studies = 6; <a href="./references#CD005351-fig-0018" title="">Analysis 1.12</a>; I<sup>2</sup> = 0%). In contrast, sensitivity analysis that excluded studies with missing data (<a href="./references#CD005351-fig-0019" title="">Analysis 1.13</a>) indicates that NPPV probably reduces ETI rates compared to SMC (RR 0.52, 95% CI 0.40 to 0.69; participants = 2248; studies = 17; I<sup>2</sup> = 0%). We performed additional post hoc analysis exploring the effect of exclusive use of face masks to deliver NPPV compared to studies with permissive use of nasal or face masks (<a href="./references#CD005351-fig-0020" title="">Analysis 1.14</a>). We found no significant subgroup differences. Exclusive face mask use (RR 0.52, 95% CI 0.40 to 0.69; participants = 2213; studies = 15; I<sup>2</sup> = 0%) or permissive use of nasal masks (RR 0.35, 95% CI 0.20 to 0.62; participants = 236; studies = 5; I<sup>2</sup> = 0%) probably reduced ETI. </p> </section> <section id="CD005351-sec-0087"> <h4 class="title">Incidence of acute myocardial infarction (AMI)</h4> <p>There is probably little or no difference in AMI incidence with NPPV compared to SMC for ACPE (RR 1.03, 95% CI 0.91 to 1.16; participants = 1313; studies = 5; <a href="./references#CD005351-fig-0021" title="">Analysis 1.15</a>; I<sup>2</sup> = 0%; moderate quality of evidence). The median length of follow‐up for AMI was three days. Subgroup analysis by NPPV type revealed no significant differences between CPAP or bilevel NPPV (<a href="./references#CD005351-fig-0022" title="">Analysis 1.16</a>; test for differences between subgroups P = 0.30). Both CPAP (RR 0.96, 95% CI 0.80 to 1.14; participants = 569; studies = 3; I<sup>2</sup> = 0%) and bilevel NPPV (RR 1.09, 95% CI 0.92 to 1.29; participants = 744; studies = 5; I<sup>2</sup> = 0%) probably have little or no difference in AMI incidence compared to SMC. Several trials reported no AMI events in either treatment arm: CPAP versus bilevel versus SMC (<a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>), and bilevel NPPV versus SMC (<a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>). Study location subgroup analysis was not possible, as only one study (<a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>) was conducted in an unknown location while the remaining studies were conducted in the ER. Baseline PaCO<sub>2</sub> subgroup analysis was not possible, as only one study (<a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] ">Park 2001</a>) had baseline eucapnia while the remaining studies had baseline hypercapnia. Our planned subgroup analysis comparing AMI rates before and after NPPV intervention was not possible, due to inconsistent AMI definitions (e.g. STEMI, NSTEMI, angina). </p> </section> <section id="CD005351-sec-0088"> <h4 class="title">Intolerance to allocated treatment</h4> <p>We were interested in obtaining information on treatment intolerance of NPPV compared to SMC. Unfortunately, this outcome was inconsistently defined. Potential outcomes providing similar information included: </p> <p> <ul id="CD005351-list-0007"> <li> <p>Treatment failure. This outcome was more commonly reported. Treatment failure could indicate the need for endotracheal intubation. This outcome was inconsistently defined and was often a clinical diagnosis. Criteria for endotracheal intubation are summarised in <a href="#CD005351-tbl-0005">Table 4</a>. </p> <ul id="CD005351-list-0008"> <li> <p><a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a> reported on treatment failure, which was defined as worsening respiratory function or reduced level of consciousness. Treatment failure occurred in one SMC participant, four CPAP participants, and one bilevel NPPV participant. Only one CPAP participant and one bilevel NPPV participant were intubated. </p> </li> <li> <p><a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a> reported on the presence of intubation criteria, which they defined as medically refractory hypoxaemia, loss of consciousness, psychomotor agitation, or haemodynamic instability. They reported 13 SMC participants and four CPAP participants meeting intubation criteria. Only six SMC participants and three CPAP participants were intubated. </p> </li> <li> <p><a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a> reported no treatment failures in the CPAP group and two treatment failures in the SMC group. </p> </li> <li> <p><a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a> reported no treatment failures or changes to the assigned treated after one hour of therapy. After 12 hours of treatment there were 11 SMC participants with coma and one CPAP participant with coma. </p> </li> <li> <p><a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a> reported treatment failure in five CPAP participants and 10 SMC participants during the first three hours of treatment, leading to endotracheal intubation. </p> </li> <li> <p><a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a> reported nine CPAP participants and 17 SMC participants meeting treatment failure criteria. Only six CPAP participants and 12 SMC participants were ultimately intubated, as the final decision was based on clinical judgement. </p> </li> <li> <p><a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a> reported on treatment failure after three hours of therapy in 13 SMC participants and seven CPAP participants. </p> </li> <li> <p><a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a> defined treatment failure based on clinical deterioration assessed by the clinician. <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a> reported that all five participants assigned to SMC had treatment failure with placebo NPPV, and were switched over to active NPPV therapy. </p> </li> </ul> </li> <li> <p>Treatment intolerance was inconsistently defined.</p> <ul id="CD005351-list-0009"> <li> <p><a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a> reported one event in each treatment group (CPAP, bilevel NPPV, and SMC) of NPPV intolerance leading to ETI. </p> </li> <li> <p><a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a> reported rates of participants changing to a new treatment, i.e. 65 of 363 SMC participants, 55 of 340 CPAP participants, and 85 of 352 participants for bilevel NPPV. </p> </li> </ul> </li> </ul> </p> <p> Given the heterogeneity in clinical definitions of treatment failure and our desired outcome being intolerance to allocated treatment, we are unable to draw any conclusions on the effect of NPPV compared to SMC for ACPE. </p> </section> <section id="CD005351-sec-0089"> <h4 class="title">Hospital and ICU length of stay</h4> <p>We are uncertain whether NPPV reduces hospital length of stay compared to SMC for ACPE (MD −0.31 days, 95% CI −1.23 to 0.61; participants = 1714; studies = 11; <a href="./references#CD005351-fig-0023" title="">Analysis 1.17</a>; I<sup>2</sup> = 55%; very low quality of evidence). The mean hospital length of stay was 9.65 days. Subgroup analysis by NPPV type found no significant subgroup differences (P = 0.22) between participants treated with CPAP (MD −0.52 days, 95% CI −1.77 to 0.72; participants = 943; studies = 7; I<sup>2</sup> = 59%) or with bilevel NPPV (MD 0.39 days, 95% CI −0.35 to 1.13; participants = 771; studies = 6; I<sup>2</sup> = 0%) compared to SMC for hospital length of stay (<a href="./references#CD005351-fig-0024" title="">Analysis 1.18</a>). Treatment location subgroup analysis identified no significant difference (P = 0.84) between ACPE participants treated with NPPV in the ER (MD −0.38 days, 95% CI −1.70 to 0.93; participants = 1455; studies = 8; I<sup>2</sup> = 68%) compared to the ICU (MD −0.21 days, 95% CI −1.30 to 0.89; participants = 259; studies = 3; <a href="./references#CD005351-fig-0025" title="">Analysis 1.19</a>; I<sup>2</sup> = 0%). Subgroup analysis by baseline PaCO<sub>2</sub> (<a href="./references#CD005351-fig-0026" title="">Analysis 1.20</a>) found a significant difference (P = 0.01) in hospital length of stay between eucapnic ACPE participants (MD −1.18 days, 95% CI −2.33 to −0.04; participants = 397; studies = 5; I<sup>2</sup> = 44%) and hypercapnic ACPE participants (MD 0.60 days, 95% CI −0.15 to 1.34; participants = 1317; studies = 6; I<sup>2</sup> = 7%). However, the evidence quality was very low, and we are uncertain whether eucapnic or hypercapnic ACPE participants had reduced hospital lengths of stay. </p> <p>We are uncertain whether NPPV reduces ICU length of stay compared to SMC for ACPE. We found significant heterogeneity with ICU length‐of‐stay data which were reported by six studies (<a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>). In addition, the quality of evidence was very low. We did not pool ICU length‐of‐stay data, due to significant heterogeneity (<a href="./references#CD005351-fig-0027" title="">Analysis 1.21</a>). We downgraded the quality of evidence for ICU length of stay by one level due to serious risk of bias. Most information was from studies at low or unclear risk of bias. Furthermore, lack of blinding was likely to lower confidence in our ICU length‐of‐stay findings. We also downgraded the evidence quality by one level due to data inconsistency. ICU length‐of stay‐data were heterogeneous with an I<sup>2</sup> of 99% and visually‐evident heterogeneity. Finally, we downgraded by one level for imprecision, because most of the trials had few participants, with the confidence interval crossing a mean difference of 0. </p> </section> <section id="CD005351-sec-0090"> <h4 class="title">Vital signs one hour after intervention</h4> <section id="CD005351-sec-0091"> <h5 class="title">Systolic blood pressure (SBP)</h5> <p>There is probably little or no difference in SBP after one hour in people with ACPE treated with NPPV compared to SMC (MD −1.72 mmHg, 95% CI −5.03 to 1.58; participants = 1408; studies = 7; <a href="./references#CD005351-fig-0028" title="">Analysis 1.22</a>; I<sup>2</sup> = 0%; moderate quality of evidence). The mean SBP was 128.4 mmHg in the SMC group. We downgraded the quality of evidence for SBP by one level for imprecision, as the included studies had few participants and wide confidence intervals. Subgroup analysis by NPPV type (<a href="./references#CD005351-fig-0029" title="">Analysis 1.23</a>) found no significant subgroup difference (P = 0.95) between SBP in people with ACPE treated with CPAP (MD −1.65 mmHg, 95% CI −5.58 to 2.28; participants = 866; studies = 7; I<sup>2</sup> = 0%) or bilevel NPPV (MD −1.89 mmHg, 95% CI −8.01 to 4.23; participants = 542; studies = 3; I<sup>2</sup> = 0%) compared to SMC. </p> </section> <section id="CD005351-sec-0092"> <h5 class="title">Diastolic blood pressure (DBP)</h5> <p>People with ACPE treated with NPPV compared to SMC probably have little or no difference in DBP after one hour of treatment (MD 1.46 mmHg, 95% CI −1.86 to 4.78; participants = 1361; studies = 6; <a href="./references#CD005351-fig-0030" title="">Analysis 1.24</a>; I<sup>2</sup> = 42%; moderate quality of evidence). The mean DBP was 71.9 mmHg in the SMC group. We downgraded DBP quality of evidence by one level for imprecision, because the included studies had few participants and wide confidence intervals. Subgroup analysis by NPPV type (<a href="./references#CD005351-fig-0031" title="">Analysis 1.25</a>) demonstrated no significant subgroup difference (P = 0.96) between DBP in people with ACPE treated with CPAP (MD 0.92 mmHg, 95% CI −3.92 to 5.75; participants = 823; studies = 6; I<sup>2</sup> = 64%) or bilevel NPPV (MD 1.08, 95% CI −2.88 to 5.04; participants = 538; studies = 3; I<sup>2</sup> = 0%) compared to SMC. </p> </section> <section id="CD005351-sec-0093"> <h5 class="title">Mean blood pressure (MBP)</h5> <p>There is probably little or no difference in MBP after one hour for people with ACPE treated with NPPV compared to SMC (MD ‐2.50 mmHg, 95% CI ‐8.29 to 3.30; participants = 251; studies = 3; I<sup>2</sup> = 20%; <a href="./references#CD005351-fig-0032" title="">Analysis 1.26</a>; moderate quality of evidence). The mean MBP was 101 mmHg. We downgraded MBP quality of evidence by one level for imprecision, because the included studies had few participants and wide confidence intervals. We did not perform subgroup analysis by NPPV type, due to the small number of studies. </p> </section> <section id="CD005351-sec-0094"> <h5 class="title">Respiratory rate (RR)</h5> <p>NPPV for ACPE probably reduces the RR after one hour of treatment compared to SMC (MD −1.87 breaths a minute, 95% CI −2.70 to −1.03; participants = 1636; studies = 10; <a href="./references#CD005351-fig-0033" title="">Analysis 1.27</a>; I<sup>2</sup> = 17%; moderate quality of evidence). The mean RR after one hour of therapy was 27.4 breaths a minute in the SMC group. We downgraded RR quality of evidence by one level for imprecision, because the included studies had few participants and wide confidence intervals. Subgroup analysis by NPPV type (<a href="./references#CD005351-fig-0034" title="">Analysis 1.28</a>) demonstrated no significant subgroup differences (P = 0.70) in RR after one hour between CPAP compared to SMC (MD −1.64 breaths a minute, 95% CI −2.41 to −0.87; participants = 1107; studies = 10; I<sup>2</sup> = 0%) and bilevel NPPV compared to SMC (MD −2.17 breaths a minute, 95% CI −4.69 to 0.35; participants = 529; studies = 3; I<sup>2</sup> = 38%). </p> </section> </section> <section id="CD005351-sec-0095"> <h4 class="title">Arterial oxygen concentration (PaO<sub>2</sub>) after one hour of intervention </h4> <p>NPPV compared to SMC for ACPE may improve PaO<sub>2</sub> after one hour of therapy (MD 16.19 mmHg, 95% CI 3.54 to 28.84; participants = 1428; studies = 10; <a href="./references#CD005351-fig-0035" title="">Analysis 1.29</a>; I<sup>2</sup> = 91%; low quality of evidence). The mean PaO<sub>2</sub> after one hour of therapy was 133.9 mmHg in the SMC group. We downgraded PaO<sub>2</sub> quality of evidence by one level due to imprecision. Most trials had few participants and the confidence interval crossed the line of no effect. We downgraded by an additional level for inconsistency, because the PaO<sub>2</sub> data were visually heterogeneous, with an I<sup>2</sup> of 91%. Our subgroup analysis by NPPV type (<a href="./references#CD005351-fig-0036" title="">Analysis 1.30</a>) demonstrated no significant subgroup differences (P = 0.42) in PaO<sub>2</sub> after one hour between CPAP compared to SMC (MD 9.55 mmHg, 95% CI −9.10 to 28.19; participants = 761; studies = 8; I<sup>2</sup> = 88%) and bilevel NPPV compared to SMC (MD 19.50 mmHg, 95% CI 4.29 to 34.71; participants = 667; studies = 6; I<sup>2</sup> = 86%). We did not pool PaCO<sub>2</sub> and pH after one hour of treatment, as these outcomes require assessment compared to baseline values. In addition, we were unable to pool the treatment failure outcome, as this composite outcome of mortality, ETI rate, and treatment intolerance was not reported. </p> </section> <section id="CD005351-sec-0096"> <h4 class="title">Adverse events</h4> <p>Eleven trials (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>; <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>) compared NPPV against SMC for ACPE and reported adverse events (<a href="./references#CD005351-fig-0037" title="">Analysis 1.31</a>). There were 228 adverse events reported in 1230 NPPV participants compared to 116 adverse events for 808 SMC participants. Adverse events included skin damage, pneumonia, gastrointestinal bleeding, gastric distention, vomiting, pneumothorax, sinusitis, mask discomfort, hypotension, arrhythmia, cardiorespiratory arrest, gastric aspiration, stroke, seizures, claustrophobia, and hypercapnia. </p> <p>Three trials (<a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>) reported that participants treated with NPPV probably have increased mask discomfort compared to SMC (RR 12.59, 95% CI 2.39 to 66.28; participants = 1100; studies = 3; I<sup>2</sup> = 0%; moderate quality of evidence). We downgraded the evidence for mask discomfort by one level for imprecision, because there were few events and wide confidence intervals. </p> <p>Three trials (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>) reported worsening hypercapnia with treatment. Participants treated with NPPV or SMC for ACPE probably have little or no difference in rates of worsening hypercapnia. We downgraded the evidence quality for hypercapnia by one level for imprecision, due to few events and wide confidence intervals. </p> <p><a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a> (n = 83) reported a higher incidence of gastric distention in the NPPV group (13/56 in NPPV group, 0/27 in SMC group; RR 13.26, 95% CI 0.82 to 215.12), but the number of events was low and the confidence interval wide. There was some weak evidence of a lower incidence of cardiorespiratory arrest in the NPPV group (24/836 (NPPV) versus 26/516 (SMC); RR 0.60, 95% CI 0.34 to 1.05). There was no evidence of a difference between groups for the other adverse events. </p> <p>Overall, we assessed the evidence for adverse events to be of low quality. We downgraded the evidence by one level for serious risk of bias (unclear or high risk of bias in at least one domain), and by one additional level for imprecision (the included studies had few participants and wide confidence intervals). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005351-sec-0097" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005351-sec-0097"></div> <section id="CD005351-sec-0098"> <h3 class="title" id="CD005351-sec-0098">Summary of main results</h3> <p>Our updated systematic review and meta‐analysis includes 24 RCTs with 2664 participants. Compared to standard medical care (SMC), the use of non‐invasive positive pressure ventilation (NPPV) for acute cardiogenic pulmonary oedema (ACPE) may reduce hospital mortality and probably reduces endotracheal intubation (ETI) rates. In addition, there was probably little or no difference between NPPV and SMC for rates of acute myocardial infarction (AMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), or mean blood pressure (MBP) after one hour of therapy. We are uncertain if NPPV reduces hospital length of stay. However, NPPV (compared to SMC) probably improves respiratory rate after one hour of treatment, may slightly improve PaO<sub>2</sub> after one hour of therapy, and probably increases mask discomfort. </p> <p>NPPV use for ACPE may reduce hospital mortality compared to SMC alone, with a number needed to treat for an additional beneficial outcome (NNTB) of 17 (NNTB 12 to NNTB 32) (<a href="./full#CD005351-tbl-0001">summary of findings Table for the main comparison</a>). Our subgroup analysis by NPPV type identified no significant difference between continuous positive airway pressure (CPAP) and bilevel NPPV subgroups. Both NPPV forms may reduce hospital mortality compared to SMC. We found no significant difference between people with ACPE treated in the Emergency Room (ER) or intensive care unit (ICU) in our subgroup analysis. NPPV may reduce hospital mortality compared to SMC in both treatment locations. Our baseline PaCO<sub>2</sub> subgroup analysis for people with ACPE treated with NPPV compared to SMC revealed a significant difference between studies with baseline average eucapnia and hypercapnia. Eucapnic people with ACPE treated with NPPV may have reduced hospital mortality, while hypercapnic people may have little or no difference in hospital mortality. The non‐significant hospital mortality benefit with hypercapnia may have been due to the greater weight of the trial by <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a> (conducted in the ER setting with baseline hypercapnia), which did not show any hospital mortality benefit with NPPV. Prior smaller studies have suggested enhanced benefit for people with baseline hypercapnia, due to their higher risk of complications and NPPV potentially preventing endotracheal intubation (<a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0053" title="MoritzF , BrousseB , GelleeB , ChajaraA , L'HerE , HellotMF , et al. Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial. Annals of Emergency Medicine2007;50(6):666‐75. [PUBMED: 17764785] ">Moritz 2007</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>). Our baseline PaCO<sub>2</sub> subgroup analysis did not support the idea that hypercapnic people with ACPE would benefit more compared to eucapnic people with ACPE. One possible reason for this discrepancy was that mean PaCO<sub>2</sub> values could hide hypercapnic people who derived significant benefit from NPPV or clinical worsening with SMC. Finally, our sensitivity analysis limited to low‐risk‐of‐bias studies found NPPV may make little or no difference in hospital mortality compared to SMC. In contrast, our sensitivity analysis limited to studies without missing data indicated that NPPV for ACPE may reduce hospital mortality compared to SMC alone. </p> <p>NPPV in ACPE probably reduces ETI compared to SMC alone, with a NNTB of 13 (NNTB 11 to 18). We did not find a significant difference between trials comparing CPAP or bilevel NPPV in our subgroup analysis. Both forms of NPPV probably reduce ETI compared to SMC. We found no significant difference between trials comparing NPPV in the ER or ICU setting in our subgroup analysis. People with ACPE treated with NPPV in the ER or ICU probably have reduced ETI compared to SMC. Baseline PaCO<sub>2</sub> subgroup analysis revealed a significant difference between baseline eucapnic and hypercapnic people with ACPE treated with NPPV compared to SMC. Both eucapnic and hypercapnic people with ACPE probably have reduced ETI compared to SMC. However, eucapnic people probably get more benefit compared to hypercapnic people. Sensitivity analysis limited to low‐risk‐of‐bias studies found NPPV use probably makes little or no difference to ETI compared with SMC. In contrast, sensitivity analysis limited to studies without missing data indicated NPPV for ACPE probably reduces ETI compared to SMC alone. Our post hoc subgroup analysis which compared exclusive use of face masks to permissive use of nasal masks revealed no significant subgroup differences, and both NPPV subgroups probably reduce ETI compared to SMC alone. </p> <p>Several trials (<a href="./references#CD005351-bbs2-0051" title="MehtaS , JayGD , WoolardRH , HiponaRA , ConnollyEM , CiminiDM , et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Critical Care Medicine1997;25(4):620‐8. ">Mehta 1997</a>; <a href="./references#CD005351-bbs2-0062" title="RusterholtzT , KempfJ , BertonC , GayolS , TournoudC , ZaehringerM , et al. Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema. Intensive Care Medicine1999;25(1):21‐8. ">Rusterholtz 1999</a>; <a href="./references#CD005351-bbs2-0063" title="SharonA , ShpirerI , KaluskiE , MoshkovitzY , MilanovO , PolakR , et al. High‐dose intravenous Isosorbide‐dinitrate is safer and better than Bi‐PAP ventilation for severe pulmonary edema. Journal of the American College of Cardiology2000;36(3):832‐7. [PUBMED: 10987607] ">Sharon 2000</a>) reported increased AMI incidence with NPPV compared to SMC. We explored the safety of NPPV by identifying studies that reported AMI during or after NPPV initiation, compared to SMC. We found there was probably little or no difference in AMI incidence with NPPV. Subgroup analysis by NPPV type did not identify a difference between CPAP or bilevel NPPV studies. An important limitation of our AMI analysis was the inconsistent AMI definitions used across studies (e.g. ST elevation MI, ECG changes, biomarker positive, symptoms) and many studies only provided baseline AMI rates (<a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. ">Frontin 2011</a>, <a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. ">L'Her 2004</a>, <a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. ">Lin 1991</a>, <a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. ">Lin 1995</a>, <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>, <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>, <a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] ">Takeda 1997</a>). </p> <p>We were unable to perform an analysis of NPPV treatment intolerance compared to SMC in ACPE, due to the outcome not being reported. Furthermore, treatment failure which was reported had inconsistent definitions. Treatment failure data suggest that not all participants meeting treatment failure criteria were intubated. Possible reasons include changes to the underlying medical therapy, participant goals of care, and the difference between a quantitative description of failure based on vital signs and blood gas values and the clinical evaluation of treatment failure. </p> <p>NPPV could reduce hospital and ICU length of stay for ACPE due to reduced ETI and avoidance of its complications (e.g. pneumonia and tracheal injury) (<a href="./references#CD005351-bbs2-0076" title="GayPC . Complications of noninvasive ventilation in acute care. Respiratory Care2009;54(2):246–57. [MEDLINE: 19173756] ">Gay 2009</a>). Ideally, studies would have provided data on ICU or hospital‐free days as participants who die early during the trial would have a short hospital or ICU length of stay, despite not benefiting from treatment. Unfortunately, hospital‐free days were not reported. We are uncertain whether NPPV reduces hospital length of stay compared to SMC for ACPE. We found no subgroup differences between participants treated with CPAP or bilevel NPPV. In addition, we found no subgroup differences between studies comparing NPPV to SMC in the ER or ICU setting. Our subgroup analysis by baseline PaCO<sub>2</sub> indicated a significant difference between eucapnic and hypercapnic studies. However, given the very low quality of evidence we are uncertain whether NPPV reduces hospital length of stay in eucapnic people with ACPE. We were unable to pool ICU length‐of‐stay data due to significant heterogeneity. Based on the available data, we are uncertain whether NPPV reduces ICU length of stay. </p> <p>We pooled mean blood pressure values obtained after one hour of therapy to identify differences between NPPV and SMC. In our comparison of NPPV to SMC in people with ACPE we found there is probably little or no difference between SBP, DBP, and MBP after one hour of therapy. These non‐significant differences may represent a true lack of difference between therapies for reducing blood pressure, or the inability of mean blood pressure values to convey any potential benefit or harm with NPPV over SMC in individuals with significant hypertension or hypotension. Our analysis of mean respiratory rate data after one hour of therapy with NPPV or SMC found that NPPV probably reduces the respiratory rate compared to SMC in ACPE. Furthermore, our analysis of PaO<sub>2</sub> after one hour of therapy demonstrated that NPPV may improve PaO<sub>2</sub> slightly compared to SMC. Finally, 16 adverse event types were reported in 11 studies. We found higher rates of face discomfort when using NPPV compared to SMC. </p> </section> <section id="CD005351-sec-0099"> <h3 class="title" id="CD005351-sec-0099">Overall completeness and applicability of evidence</h3> <p>Our objective in performing this systematic review and meta‐analysis update was to evaluate the impact of new literature published since the last version of this review (May 2013, <a href="./references#CD005351-bbs2-0110" title="VitalFMR , LadeiraMT , AtallahÁN . Non‐invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD005351.pub3] ">Vital 2013</a>) on the safety and effectiveness of NPPV compared to SMC for ACPE. Furthermore, we have updated the protocol and conduct of the review to recently‐revised Cochrane standards (<a href="./references#CD005351-bbs2-0081" title="HigginsJP , LassersonT , ChandlerJ , ToveyD , ChurchillR . Methodological Expectations of Cochrane Intervention Reviews. community.cochrane.org/mecir‐manual 2018 (accessed 25 March 2019). ">Higgins 2018</a>). We reassessed the literature and performed a new assessment for study eligibility, which identified 24 RCTs for inclusion. Of these, seven are new studies published since the last version of this review (<a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). ">Ducros 2011</a>; <a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] ">El‐Refay 2016</a>; <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>; <a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] ">Zokaei 2016</a>). Three newly‐included studies are based on a reassessment of previously excluded studies (<a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a>; <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a>; <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a>), which lacked extractable outcomes. The outcomes in these trials were measured on different time scales for our secondary outcomes: <a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. ">Li 2005</a> (PaO<sub>2</sub>, respiratory rate), <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a> (PaO<sub>2</sub>, respiratory rate, SBP), and <a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] ">Moritz 2003</a> (SBP, DBP). Only <a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. ">Hao 2002</a> provided data on ETI as a primary outcome. </p> <p>Importantly, we also excluded 15 studies that we had included in the previous version of this review but that no longer meet the revised inclusion criteria. For transparency, these were four quasi‐randomised controlled trials (<a href="./references#CD005351-bbs2-0034" title="BerstenAD , HoltAW , VedigAE , SkowronskiGA , BagooleyCJ . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. New England Journal of Medicine1991;325(26):1825‐30. ">Bersten 1991</a>; <a href="./references#CD005351-bbs2-0053" title="MoritzF , BrousseB , GelleeB , ChajaraA , L'HerE , HellotMF , et al. Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial. Annals of Emergency Medicine2007;50(6):666‐75. [PUBMED: 17764785] ">Moritz 2007</a>; <a href="./references#CD005351-bbs2-0063" title="SharonA , ShpirerI , KaluskiE , MoshkovitzY , MilanovO , PolakR , et al. High‐dose intravenous Isosorbide‐dinitrate is safer and better than Bi‐PAP ventilation for severe pulmonary edema. Journal of the American College of Cardiology2000;36(3):832‐7. [PUBMED: 10987607] ">Sharon 2000</a>; <a href="./references#CD005351-bbs2-0067" title="WeitzG , StruckJ , ZonakA , BalnusS , PerrasB , DodtC . Prehospital noninvasive pressure support ventilation for acute cardiogenic pulmonary edema. European Journal of Emergency Medicine2007;14(5):276‐9. ">Weitz 2007</a>), three studies conducted on an ineligible population (<a href="./references#CD005351-bbs2-0028" title="BautinA , KhubulavaG , NaumovA , GarifzjanovA , EtinV . NPPV in the treatment of the cardiogenic edema (CPE) after heart surgery. European Respiratory Journal2005;26(Suppl 49):3112. ">Bautin 2005</a>; <a href="./references#CD005351-bbs2-0038" title="DelclauxC , L'HerE , AlbertiC , ManceboJ , AbrougF , ContiG , et al. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivery by a face mask. JAMA2000;284:2352‐60. ">Delclaux 2000</a>; <a href="./references#CD005351-bbs2-0042" title="FerrerM , EsquinasA , LeonM , GonzalezG , AlarconA , TorresA . Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. American Journal of Respiratory and Critical Care Medicine2003;168(12):1438‐44. ">Ferrer 2003</a>) and eight studies which compared CPAP to bilevel NPPV without a SMC arm (<a href="./references#CD005351-bbs2-0031" title="BelloneA , MonariA , CortellaroF , VetorelloM , ArlatiS , CoenD . Myocardial infarction rate in acute pulmonary edema: noninvasive support ventilation versus continuous positive airway pressure. Critical Care Medicine2004;32(9):1860‐5. ">Bellone 2004</a>; <a href="./references#CD005351-bbs2-0032" title="BelloneA , VettorelloM , MonariA , CortellaroF , CoenD . Noninvasive pressure support ventilation vs. continuous positive airway pressure in acute hypercapnic pulmonary edema. Intensive Care Medicine2005;31:807‐11. ">Bellone 2005</a>; <a href="./references#CD005351-bbs2-0040" title="FerrariG , OlliveriF , DeFilippiG , MilanA , ApraF , BoccuzziA , et al. Noninvasive positive airway pressure and risk of myocardial infarction in acute cardiogenic pulmonary edema: continuous positive airway pressure vs noninvasive positive pressure ventilation. Chest2007;132(6):1804‐9. ">Ferrari 2007</a>; <a href="./references#CD005351-bbs2-0041" title="FerrariG , GroffP , DeFilippiG , GiostraF , MazzoneM , PotaleG , et al. Continuous positive airway pressure (CPAP) vs. noninvasive positive pressure ventilation (NIV) in acute cardiogenic pulmonary edema (ACPE): A prospective randomized multicentric study. Journal of Emergency Medicine2006;30:246‐7. FerrariG , MilanA , GroffP , PagnozziF , MazzoneM , MolinoP , et al. Continuous positive airway pressure vs. pressure support ventilation in acute cardiogenic pulmonary edema: a randomized trial. Journal of Emergency Medicine2010;39(5):676‐84. NCT00446498 . CPAP Versus NPPV in ACPE [Continuous positive airway pressure versus non‐invasive positive pressure support ventilation in acute cardiogenic pulmonary oedema: a prospective randomised multicentre trial]. clinicaltrials.gov/show/nct00446498 (first received 13 March 2007). ">Ferrari 2010</a>; <a href="./references#CD005351-bbs2-0043" title="BordonaliT , FontanellaB , AffatatoA , SaporettiA , CarubelliV , CiccareseC , et al. Comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (NIPSV) in acute cardiogenic pulmonary edema. European Heart Journal2009;30:369. [EMBASE: 797] FontanellaB , AffatatoA , CiccareseC , SacchiniM , VolpiniM , BianchettiF , et al. Prospective comparison of continuous positive airway pressure (CPAP) versus bilevel non invasive pressure support ventilation (BPAP) in acute cardiogenic pulmonary edema. European Heart Journal Supplements2010;12 (supplement F):F37‐F38. ">Fontanella 2010</a>; <a href="./references#CD005351-bbs2-0049" title="LieschingT , NelsonDL , CormierKL , SucovA , ShortK , WarburtonR , et al. Randomized trial of bilevel versus continuous positive airway pressure for acute pulmonary edema. Journal of Emergency Medicine2014;46(1):130‐40. [PUBMED: 24071031] LieschingTN , CromierK , NelsonD , ShortK , SucovA , HillNS . Bilevel noninvasive ventilation vs continuous positive airway pressure to treat acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;167(Suppl 7):27. ">Liesching 2014</a>; <a href="./references#CD005351-bbs2-0050" title="Martin‐BermudezR , Rodríguez‐PortalJ , García‐GarmendiaJ . Non‐invasive ventilation in cardiogenic pulmonary edema. Preliminary results of a randomized trial. Intensive Care Medicine2002;28:S68. ">Martin‐Bermudez 2002</a>; <a href="./references#CD005351-bbs2-0051" title="MehtaS , JayGD , WoolardRH , HiponaRA , ConnollyEM , CiminiDM , et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Critical Care Medicine1997;25(4):620‐8. ">Mehta 1997</a>). </p> <p>Overall, the evidence we identified was able to address our review objective. Studies that we identified focused on a single acute intervention (NPPV versus SMC) for people with ACPE provided during their hospital presentation. Our inclusion criteria for adults with ACPE were met. However, diagnosis of ACPE across studies was not standardised but based on a clinical assessment supported by clinical signs, chest x‐ray, and exclusion of important alternative causes of dyspnoea (e.g. chronic obstructive pulmonary disease (COPD) and pneumonia). An important limitation of the studies we identified was the lack of baseline demographic data that could explain why certain recruited participants were at higher mortality risk than others (e.g. severe untreated valvular heart disease or AHA stage D heart failure). For example, the mortality rates reported by included studies were extremely disparate, ranging from 0 to 27.91% for NPPV (mean 9.64%) and 0 to 63.64% for SMC (mean 21.06%). These large variations in mortality may be influenced by the recruitment of ACPE participants with different underlying risks of mortality, regardless of their aggressive medical treatment with SMC or NPPV or both, and subtle differences in SMC between the different countries in which the included trials were performed. </p> <p>Regarding the interventions under study, the trials included CPAP or bilevel NPPV or both, that had adjustable settings. We tried to ascertain whether the specific devices and pressure settings were reflective of contemporary practice. However, the NPPV device settings were not completely reported for all included trials. Where available, we have reported the mean inspiratory positive airway pressure (IPAP), expiratory positive airway pressure (EPAP), positive end‐expiratory pressure (PEEP), and duration of NPPV used by each study (<a href="#CD005351-tbl-0002">Table 1</a>). For studies where this information was available, the devices and settings do reflect contemporary practice. </p> <p>In addition, the ideal trial would have compared both forms of NPPV against SMC, given the possibility that CPAP versus bilevel NPPV may differ in their treatment efficacy. Only six of 24 included trials used a three‐arm design. One such study (<a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>) was the largest RCT performed to date (N = 1069). The other five studies had smaller sample sizes (range 26 to 129; mean 73). The remaining studies compared one type of NPPV (bilevel NPPV or CPAP) against SMC. Subgroup analysis by type of NPPV did not reveal any significant differences for the primary or main secondary outcomes. Current ACPE treatment practices vary from targeting an oxygen saturation of greater than 92% by titration of FiO<sub>2</sub>, initiation of NPPV, or endotracheal intubation (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>). Finally, we considered whether the SMC used in each trial reflected current treatment guidelines (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>; <a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>). Such contemporary guidelines for acute heart failure recommend therapy with intravenous loop diuretics, supplemental oxygen, and nitrates, while maintaining an adequate blood pressure (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>; <a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>). Our summary of the SMC used in each trial is listed in <a href="#CD005351-tbl-0003">Table 2</a>. All studies provided loop diuretics. However, the doses provided were unclear in nine studies. Nitrates were provided in all trials, but the form and dose was unclear in two studies. Similarly, each trial provided supplemental oxygen, but the specific FiO<sub>2</sub> used was unclear in two studies. In summary, the NPPV and SMC used by the included studies generally reflected contemporary clinical practice </p> </section> <section id="CD005351-sec-0100"> <h3 class="title" id="CD005351-sec-0100">Quality of the evidence</h3> <p>All outcomes were assessed according to GRADE recommendations (<a href="./references#CD005351-bbs2-0077" title="GuyattGH , OxmanAD , VistG , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. [DOI: 10.1136/bmj.39489.470347.AD] ">Guyatt 2008</a>; <a href="./references#CD005351-bbs2-0080" title="HigginsJP , ChurchillR , ChandlerJ , CumpstonMS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook2017. ">Higgins 2017</a>). For the main outcomes, evidence quality ranged from moderate (ETI, AMI), to low (hospital mortality, adverse events), to very low (hospital length of stay). Hospital mortality was assessed in 21 studies that compared NPPV versus SMC and included 2484 patients. Key methodological limitations of the meta‐analysis include the clinical heterogeneity of included studies, such as variation in the aetiology of cardiogenic pulmonary oedema (e.g. myocardial ischaemia, severe valvular heart disease) and the lack of clinical context for each individual participant (e.g. home therapies, ACC/AHA heart failure grade). Additional limitations were the impracticality of blinding participants, personnel, and outcome assessment, given the nature of NPPV. Lack of blinding may have influenced objective outcomes (e.g. hospital mortality or ETI) because participants treated with SMC could potentially cross over to NPPV if they appeared to be clinically deteriorating, thereby attenuating the benefit of NPPV when using intention‐to‐treat analysis. Another limitation of the included studies was the unclear risk of selective reporting bias, as reflected by the inconsistent reporting of outcomes. Finally, most studies recruited a low number of participants and their primary outcome was not hospital mortality. Interestingly, the well‐powered study by <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a> which had hospital mortality as a primary outcome did not detect a mortality difference between NPPV and SMC. </p> <p>Our GRADE quality of evidence assessments for our primary outcomes were influenced by a number of factors, including risk of bias, imprecision, and inconsistency. Specifically, we rated the hospital mortality outcome as low quality, due to serious concerns with risks of bias and imprecision. We downgraded evidence quality by one level for risk of bias because most trials were rated as having unclear or high risk of bias for key domains, which included: randomisation sequence generation, allocation concealment, selective reporting bias, and other significant bias. We also downgraded this outcome for imprecision because there were few mortality events and the confidence interval included the appreciable benefit risk ratio of 0.75. The funnel plot for hospital mortality (<a href="#CD005351-fig-0004">Figure 4</a>) was also asymmetrical, which suggests the presence of publication bias. However, we did not further downgrade the evidence for this outcome, as the asymmetry could be explained by the poor design of smaller studies included in our review, clinical heterogeneity, and sampling variation. Furthermore, the findings were consistent in a post hoc fixed‐effect sensitivity analysis (<a href="./references#CD005351-fig-0013" title="">Analysis 1.7</a>; <a href="./references#CD005351-bbs2-0101" title="SterneJA , SuttonAJ , IoannidisJP , TerrinN , JonesDR , LauJ , et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ2011;343:d4002. [DOI: 10.1136/bmj.d4002] ">Sterne 2011</a>). </p> <p>We rated the quality of evidence for ETI as moderate. We downgraded this outcome by one level, due to serious concerns with risks of bias. Most trials that provided ETI evidence had unclear or high risk of bias for key domains, which included: randomisation sequence generation, allocation concealment, selective reporting bias, and other significant bias. Our ETI funnel plot (<a href="#CD005351-fig-0005">Figure 5</a>) was symmetrical, which suggests the absence of graphical evidence of publication bias. For AMI, the quality of evidence was moderate. We downgraded the evidence by one level for serious concerns with imprecision. We downgraded for imprecision because few trials reported AMI events, the confidence interval crossed a risk ratio of 1, and the AMI definition varied between trials. We rated hospital length‐of‐stay evidence quality as very low, and downgraded it for the following reasons: serious risk of bias due to lack of blinding, visually heterogeneous data, and high imprecision with few participants and a confidence interval crossing a mean difference of 0. Our hospital length‐of‐stay funnel plot (<a href="#CD005351-fig-0006">Figure 6</a>) was symmetrical and we therefore did not downgrade the evidence for publication bias. Adverse events evidence quality was low, and downgraded for the following reasons: serious risk of bias due to most studies having at least one domain at unclear or high risk of bias, and imprecision with wide confidence intervals crossing a risk ratio of 1 for many of the reported adverse events. For our secondary outcomes SBP, DBP, MBP, respiratory rate and PaO<sub>2</sub>, the quality of evidence was moderate. We downgraded SBP, DBP, MBP, and respiratory rate evidence quality by one level for imprecision because the included studies had few participants and wide confidence intervals. We downgraded PaO<sub>2</sub> evidence quality by one level due to imprecision, because most trials had few participants and the confidence interval crossed a mean difference of 0. In summary, the quality of evidence was low or very low for most primary outcomes, except for ETI and AMI, which were moderate and have important clinical significance. </p> <div class="figure" id="CD005351-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.8 ETI RATE." data-id="CD005351-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.8 ETI RATE.</p> </div> </div> </div> <div class="figure" id="CD005351-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.17 HOSPITAL LENGTH OF STAY." data-id="CD005351-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.17 HOSPITAL LENGTH OF STAY.</p> </div> </div> </div> </section> <section id="CD005351-sec-0101"> <h3 class="title" id="CD005351-sec-0101">Potential biases in the review process</h3> <p>Our review is strengthened by using prespecified methods to reduce bias. We reduced bias in our search strategy by searching eight databases including clinical trial databases without language restrictions. After obtaining reference lists, we minimised bias through duplicate independent screening, duplicate data abstraction, and prespecified criteria for appraising methodological quality. In addition, the study protocol was established prospectively and followed the Cochrane format for systematic reviews (<a href="./references#CD005351-bbs2-0081" title="HigginsJP , LassersonT , ChandlerJ , ToveyD , ChurchillR . Methodological Expectations of Cochrane Intervention Reviews. community.cochrane.org/mecir‐manual 2018 (accessed 25 March 2019). ">Higgins 2018</a>; <a href="./references#CD005351-bbs2-0083" title="JadadAR , MoherM , BrowmanGP , BookerL , SigouinC , FuentesM , et al. Systematic reviews and meta‐analyses on treatment of asthma: critical evaluation. BMJ2000;320(7234):537‐40. ">Jadad 2000</a>; <a href="./references#CD005351-bbs2-0089" title="McKibbonKA , WilczynskiNL , HaynesRB . What do evidence‐based secondary journals tell us about the publication of clinically important article in primary healthcare journals?. BMC Medicine2004;2:33. ">McKibbon 2004</a>). Furthermore, two of our review authors (NB, FV) obtained additional data from study authors for outcomes incompletely described in their initial publication (<a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). ">Agmy 2008</a>; <a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. ">Austin 2013</a>; <a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. ">Crane 2004</a>; <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>; <a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. ">Kelly 2002</a>; <a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. ">Masip 2000</a>; <a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] ">Nava 2003</a>; <a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] ">Park 2004</a>; <a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] ">Räsänen 1985</a>; <a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] ">Takeda 1998</a>; <a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] ">Thys 2002</a>). Our meta‐analysis includes the largest number of trials exploring the role of NPPV compared to SMC in ACPE and had increased power in pooling outcomes compared to earlier reviews (<a href="./references#CD005351-bbs2-0096" title="PottsJM . Noninvasive positive pressure ventilation: effect on mortality in acute cardiogenic pulmonary edema: a pragmatic meta‐analysis. Polskie Archiwum Medycyny Wewnętrznej2009;119(6):349‐52. ">Potts 2009</a>; <a href="./references#CD005351-bbs2-0104" title="WengCL , ZhaoYT , LiuQH , FuCJ , SunF , MaYL , et al. Meta‐analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema. Annals of Internal Medicine2010;152(9):590‐600. ">Weng 2010</a>). We performed extensive analysis of the impact of NPPV on a broad range of clinically important outcomes and physiological parameters. Furthermore, our results were robust to the exclusion of studies with missing data. The generalisability of our findings is enhanced by the broad range of treatment locations and countries included, representing international experience with NPPV for ACPE. </p> <p>The small number of events (e.g. mortality, ETI, AMI) within identified trials is one important limitation of our review and meta‐analysis. Additionally, the underlying heterogeneity of included ACPE participants may have influenced our findings on hospital mortality and ETI. Several important prognostic factors were not clearly reported by trial investigators, such as the participants’ underlying heart failure severity, compliance with guideline‐appropriate home therapy, and presence of heart failure aetiologies requiring surgical interventions (e.g. severe valvular heart disease). Furthermore, there were slight variations in SMC among studies, which suggest that clinical heterogeneity may have influenced some of the treatment effects. Additionally, the definition of AMI was inconsistent across studies. Finally, intubation criteria were not standardised and variations in clinical practice could have influenced the observed differences in ETI. </p> </section> <section id="CD005351-sec-0102"> <h3 class="title" id="CD005351-sec-0102">Agreements and disagreements with other studies or reviews</h3> <p>The first systematic review on NPPV for ACPE included three trials and reported a significant reduction in ETI with CPAP compared to SMC (<a href="./references#CD005351-bbs2-0093" title="PangD , KeenanSP , CookDJ , SibbaldWJ . The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema: a systematic review. Chest1998;114(4):1185‐92. [MEDLINE: 9792593] ">Pang 1998</a>). <a href="./references#CD005351-bbs2-0078" title="HessDR . The evidence for noninvasive positive‐pressure ventilation in the care of patients in acute respiratory failure: a systematic review of the literature. Respiratory Care2004;49(7):810–29. [PUBMED: 15222912] ">Hess 2004</a> expressed concern about the use of NPPV for ACPE, due to greater AMI rates in two studies and no significant benefit for mortality or ETI. <a href="./references#CD005351-bbs2-0090" title="NadarS , PrasadN , TaylorRS , LipGY . Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta‐analysis. International Journal of Cardiology2005;99(2):171‐85. [DOI: 10.1016/j.ijcard.2004.03.047] ">Nadar 2005</a> identified reduced ETI for CPAP compared to SMC with no significant mortality difference. Several meta‐analyses have reported similar conclusions to our own (<a href="./references#CD005351-bbs2-0073" title="CollinsSP , MielniczukLM , WhittinghamHA , BoseleyME , SchrammDR , StorrowAB . The use of noninvasive ventilation in emergency department patients with acute cardiogenic pulmonary edema: a systematic review. Annals of Emergency Medicine2006;48(3):260‐9. ">Collins 2006</a>; <a href="./references#CD005351-bbs2-0082" title="HoKM , WongK . A comparison of continuous and bi‐level positive airway pressure non‐invasive ventilation in patients with acute cardiogenic pulmonary oedema: a meta‐analysis. Critical Care2006;10(2):R49. ">Ho 2006</a>; <a href="./references#CD005351-bbs2-0088" title="MasipJ , RoqueM , SanchezB , FernandezR , SubiranaM , ExpositoJA . Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta‐analysis. JAMA2005;294(24):3124‐30. ">Masip 2005</a>; <a href="./references#CD005351-bbs2-0094" title="PeterJV , MoranJL , Phillips‐HughesJ , GrahamP , BerstenAD . Effect of non‐invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta‐analysis. Lancet2006;367:1155‐63. ">Peter 2006</a>; <a href="./references#CD005351-bbs2-0104" title="WengCL , ZhaoYT , LiuQH , FuCJ , SunF , MaYL , et al. Meta‐analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema. Annals of Internal Medicine2010;152(9):590‐600. ">Weng 2010</a>; <a href="./references#CD005351-bbs2-0105" title="WinckJC , AzevedoLF , Costa‐PereiraA , AntonelliM , WyattJC . Efficacy and safety of non‐invasive ventilation in the treatment of acute cardiogenic pulmonary edema ‐ a systematic review and meta‐analysis. Critical Care (London, England)2006;10(2):R69. ">Winck 2006</a>), despite small differences in methodology. The results of previous systematic reviews were challenged by a large new RCT (<a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>), which found no significant differences in hospital mortality or ETI between CPAP, bilevel NPPV, and SMC. Important caveats within <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a> include exclusion of people requiring an emergent intervention who could possibly benefit from NPPV, exclusion of people with AMI undergoing an intervention, and cross‐overs between treatment arms of 19.9% (SMC), 16.2% (CPAP), and 24.1% (bilevel NPPV) (<a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a>). There was evidence in <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a> that SMC cross‐overs had more severe illness, and their cross‐over to NPPV could have attenuated the benefit with NPPV compared to SMC. Nevertheless, as the largest single trial to date, <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a> is an important trial in the meta‐analysis and its results contrast with those of smaller included studies, which tend to show greater effect estimates favouring NPPV over SMC. The negative results of <a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). ">Gray 2008</a> make it imperative that we are cautious in interpreting the overall findings of our meta‐analysis, which demonstrated that NPPV may reduce hospital mortality and probably reduces ETI when compared to SMC. </p> <p>Our main findings are important and add support to current European heart failure guidelines (<a href="./references#CD005351-bbs2-0095" title="PonikowskiP , VoorsAA , AnkerSD , BuenoH , ClelandJG , CoatsAJ , et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal2016;37(27):2129‐200. [DOI: 10.1093/eurheartj/ehw128] ">Ponikowski 2016</a>). This guideline recommends that NPPV be considered and initiated promptly in people with ACPE presenting with tachypnoea (respiratory rate higher than 25 breaths a minute) and hypoxia (SpO<sub>2</sub> less than 90%). In contrast, our findings may challenge Canadian heart failure guidelines which recommend against routine use of NPPV in ACPE (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>). The Canadian heart failure guideline suggests starting with SMC and considering NPPV if there is persistent hypoxia (<a href="./references#CD005351-bbs2-0075" title="EzekowitzJA , O'MearaE , McDonaldMA , AbramsH , ChanM , DucharmeA , et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology2017;33(11):1342‐433. [PUBMED: 29111106] ">Ezekowitz 2017</a>). Based on our findings, their recommendation may be too conservative. Furthermore, NPPV is a relatively benign intervention. The main harms that were evident in our review were increased mask discomfort compared to SMC. Overall, the results of our review suggest that people with ACPE may experience more benefits than harms from the addition of NPPV to SMC for ACPE. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005351-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA statement flow diagram for 2019 review update." data-id="CD005351-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA statement flow diagram for 2019 review update.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005351-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005351-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.1 HOSPITAL MORTALITY." data-id="CD005351-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.1 HOSPITAL MORTALITY.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.8 ETI RATE." data-id="CD005351-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.8 ETI RATE.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.17 HOSPITAL LENGTH OF STAY." data-id="CD005351-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 NPPV vs SMC, outcome: 1.17 HOSPITAL LENGTH OF STAY.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 1 HOSPITAL MORTALITY." data-id="CD005351-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 1 HOSPITAL MORTALITY.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 2 Hospital mortality ‐ by NPPV." data-id="CD005351-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 2 Hospital mortality ‐ by NPPV.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 3 Hospital mortality ‐ by location." data-id="CD005351-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 3 Hospital mortality ‐ by location.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 4 Hospital mortality ‐ by baseline PaCO2." data-id="CD005351-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 4 Hospital mortality ‐ by baseline PaCO<sub>2</sub>. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 5 Hospital mortality ‐ sensitivity analysis (low risk of bias)." data-id="CD005351-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 5 Hospital mortality ‐ sensitivity analysis (low risk of bias). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 6 Hospital mortality ‐ sensitivity analysis (missing data)." data-id="CD005351-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 6 Hospital mortality ‐ sensitivity analysis (missing data). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 7 Hospital mortality ‐ sensitivity analysis (fixed‐effect)." data-id="CD005351-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 7 Hospital mortality ‐ sensitivity analysis (fixed‐effect).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-08.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 8 ETI RATE." data-id="CD005351-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 8 ETI RATE.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 9 ETI rate ‐ by NPPV." data-id="CD005351-fig-0015" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 9 ETI rate ‐ by NPPV.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 10 ETI rate ‐ by location." data-id="CD005351-fig-0016" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 10 ETI rate ‐ by location.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 11 ETI rate ‐ by baseline PaCO2." data-id="CD005351-fig-0017" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 11 ETI rate ‐ by baseline PaCO<sub>2</sub>. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 12 ETI rate ‐ sensitivity analysis (low risk of bias)." data-id="CD005351-fig-0018" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 12 ETI rate ‐ sensitivity analysis (low risk of bias). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 13 ETI rate ‐ sensitivity analysis (missing data)." data-id="CD005351-fig-0019" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 13 ETI rate ‐ sensitivity analysis (missing data).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 14 ETI rate ‐ by face mask type." data-id="CD005351-fig-0020" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 14 ETI rate ‐ by face mask type.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 15 ACUTE MI INCIDENCE." data-id="CD005351-fig-0021" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 15 ACUTE MI INCIDENCE.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 16 Acute MI incidence ‐ by NPPV." data-id="CD005351-fig-0022" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 16 Acute MI incidence ‐ by NPPV.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-17.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 17 HOSPITAL LENGTH OF STAY." data-id="CD005351-fig-0023" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 17 HOSPITAL LENGTH OF STAY.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 18 Hospital length of stay ‐ by NPPV." data-id="CD005351-fig-0024" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 18 Hospital length of stay ‐ by NPPV.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 19 Hospital length of stay ‐ by location." data-id="CD005351-fig-0025" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 19 Hospital length of stay ‐ by location.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 20 Hospital length of stay ‐ by baseline PaCO2." data-id="CD005351-fig-0026" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 20 Hospital length of stay ‐ by baseline PaCO<sub>2</sub>. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 21 ICU LENGTH OF STAY." data-id="CD005351-fig-0027" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 21 ICU LENGTH OF STAY.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 22 SYSTOLIC BP AFTER ONE HOUR." data-id="CD005351-fig-0028" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 22 SYSTOLIC BP AFTER ONE HOUR.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 23 Systolic BP after one hour ‐ by NPPV." data-id="CD005351-fig-0029" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 23 Systolic BP after one hour ‐ by NPPV.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 24 DIASTOLIC BP AFTER ONE HOUR." data-id="CD005351-fig-0030" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 24 DIASTOLIC BP AFTER ONE HOUR.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 25 Diastolic BP after one hour ‐ by NPPV." data-id="CD005351-fig-0031" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 25 Diastolic BP after one hour ‐ by NPPV.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 26 MEAN BP AFTER ONE HOUR." data-id="CD005351-fig-0032" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 26 MEAN BP AFTER ONE HOUR.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 27 RESPIRATORY RATE AFTER ONE HOUR." data-id="CD005351-fig-0033" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 27 RESPIRATORY RATE AFTER ONE HOUR.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 28 Respiratory rate after one hour ‐ by NPPV." data-id="CD005351-fig-0034" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 28 Respiratory rate after one hour ‐ by NPPV.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 29 PaO2 (mmHg) AFTER ONE HOUR." data-id="CD005351-fig-0035" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 29 PaO<sub>2</sub> (mmHg) AFTER ONE HOUR. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 30 PaO2 (mmHg) after one hour ‐ by NPPV." data-id="CD005351-fig-0036" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 30 PaO<sub>2</sub> (mmHg) after one hour ‐ by NPPV. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005351-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/urn:x-wiley:14651858:media:CD005351:CD005351-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_t/tCD005351-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NPPV vs SMC, Outcome 31 ADVERSE EVENTS." data-id="CD005351-fig-0037" src="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 NPPV vs SMC, Outcome 31 ADVERSE EVENTS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/media/CDSR/CD005351/image_n/nCD005351-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005351-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">NPPV compared to SMC for cardiogenic pulmonary oedema</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>NPPV compared to standard medical care for cardiogenic pulmonary oedema</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> People with cardiogenic pulmonary oedema<br/> <b>Setting:</b> Pre‐hospital intensive care, emergency department, coronary care unit, or intensive care unit<br/> <b>Intervention:</b> NPPV<br/> <b>Comparison:</b> Standard medical care (SMC) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with SMC</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with NPPV</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>HOSPITAL MORTALITY<br/> follow‐up: median 13 days; range 1 day ‐ 41 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.65<br/> (0.51 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2484<br/> (21 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>176 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>114 per 1000<br/> (90 to 144) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ETI RATE<br/> follow‐up: median 1 day; </p> <p>range 0.1 day ‐ 30 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.49<br/> (0.38 to 0.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2449<br/> (20 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>154 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>75 per 1000<br/> (58 to 95) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>ACUTE MI INCIDENCE<br/> follow‐up: median 3 days; range 1 day ‐ 41 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.91 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1313<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>421 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>433 per 1000<br/> (383 to 488) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HOSPITAL LENGTH OF STAY</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean HOSPITAL LENGTH OF STAY was 9.65 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.31 days lower<br/> (1.23 lower to 0.61 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1714<br/> (11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>e,f,g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU LENGTH OF STAY</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>This outcome could not be pooled due to high heterogeneity. There was no evidence of a difference between NPPV and SMC in 4 RCTs, and 2 RCTs reported a shorter length of stay for NPPV (1 day shorter (95% CI −1.79 to −0.21); n = 30; 4 days shorter (95% CI −4.36 to −3.64); n = 120) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>587<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>h,i,j</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were not pooled due to high heterogeneity with an I<sup>2</sup> of 99% </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>INTOLERANCE TO ALLOCATED TREATMENT ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ADVERSE EVENTS</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Reported adverse events included skin damage, pneumonia, gastrointestinal bleeding, gastric distention, vomiting, pneumothorax, sinusitis, mask discomfort, hypotension, arrhythmia, cardiorespiratory arrest, gastric aspiration, stroke, seizures, claustrophobia, and hypercapnia. </p> <p>There was no evidence of a difference between groups for most of these events. However, there was an increase in discomfort with mask reported with NPPV (35/658) compared with SMC (0/442); RR 12.59 (95% CI 2.39 to 66.28). </p> <p>One small study (n = 83) reported a higher incidence of gastric distention in the NPPV group (13/56 in NPPV group, 0/27 in SMC group; RR 13.26 (95% CI 0.82 to 215.12)), but the number of events was low and the confidence interval wide. There was also some weak evidence of a lower incidence of cardiorespiratory arrest in the NPPV group (24/836 (NPPV) vs 26/516 (SMC); RR 0.60 (95% CI 0.34 to 1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2038<br/> (11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>k,l</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for risk of bias. Most trials providing hospital mortality evidence were at unclear or high risk of bias for key domains, including: randomisation sequence, allocation concealment, selective reporting bias, and other significant bias.<br/> <sup>b</sup>Downgraded by one level for imprecision. Most trials had few participants and few mortality events, with a confidence interval crossing a RR of 0.75.<br/> <sup>c</sup>Downgraded by one level for risk of bias. Most trials providing ETI evidence were rated as having unclear or high risk of bias for key domains, which included randomisation sequence generation, allocation concealment, selective reporting bias, and other significant bias.<br/> <sup>d</sup>Downgraded by one level for imprecision. Most trials had few participants and few acute MI events, with a confidence interval crossing a RR of 1.0. In addition, the definition of acute MI varied between trials, with some trials using creatinine kinase and others using troponin.<br/> <sup>e</sup>Downgraded by one level for risk of bias. Most trials were at low or unclear risk of bias. Potential limitations from lack of blinding are likely to lower confidence in hospital length of stay.<br/> <sup>f</sup>Downgraded by one level for inconsistency. Hospital length of stay was heterogeneous, with an I<sup>2</sup> of 58% and visually‐evident heterogeneity.<br/> <sup>g</sup>Downgraded by one level for imprecision. Most trials had few participants, with a confidence interval crossing a MD of 0.<br/> <sup>h</sup>Downgraded by one level for risk of bias. Most information was from studies at low or unclear risk of bias. Potential limitations from lack of blinding are likely to lower confidence in ICU length of stay.<br/> <sup>i</sup>Downgraded by one level for imprecision. Most trials had few participants, with a confidence interval crossing a MD of 0.<br/> <sup>j</sup>Downgraded by one level for inconsistency. ICU length of stay was heterogeneous, with an I<sup>2</sup> of 99% and visually‐evident heterogeneity.<br/> <sup>k</sup>Downgraded by one level for risk of bias. Most studies had at least one domain at high or unclear risk of bias.<br/> <sup>l</sup>Downgraded by one level for imprecision, as confidence intervals included both directions of effect for many of the adverse events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">NPPV compared to SMC for cardiogenic pulmonary oedema</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005351-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">NPPV intervention summary: EPAP, IPAP, and PEEP settings, duration of therapy.</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mask type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>IPAP level (cmH2O) ± SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EPAP in bilevel NPPV (cmH2O) ± SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PEEP in CPAP (cmH2O) ± SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time of bilevel NPPV (h) ± SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time of CPAP (h) ± SD</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). "><b>Agmy 2008</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. "><b>Austin 2013</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.583333</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. "><b>Crane 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). "><b>Ducros 2011</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] "><b>El‐Refay 2016</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. "><b>Frontin 2011</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). "><b>Gray 2008</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14±5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 ± 3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 ± 4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 ± 1.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.2 ± 1.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. "><b>Hao 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.6 ± 2.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. "><b>Kelly 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. "><b>L'Her 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. "><b>Levitt 2001</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask selected for mouth breathers Nasal available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. "><b>Li 2005</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 to 18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 to 8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. "><b>Lin 1991</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. "><b>Lin 1995</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. "><b>Masip 2000</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.2 ± 2.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2 ± 1.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] "><b>Moritz 2003</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.3 ± 0.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] "><b>Nava 2003</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.5 ± 21.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.1 ± 3.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.4 ± 3.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] "><b>Park 2001</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nasal bilevel and face mask for CPAP</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> 12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.6 ± 0.6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.8 ± 1.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] "><b>Park 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17 ± 2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 ± 2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 ± 2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.1 ± 1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.7 ± 0.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] "><b>Räsänen 1985</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] "><b>Takeda 1997</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nasal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.9 ± 8.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] "><b>Takeda 1998</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nasal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] "><b>Thys 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.5 ± 3.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.1 ± 1.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.3 ± 0.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] "><b>Zokaei 2016</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Face mask 1st, nasal 2nd</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 to 20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Not all papers provided a mean and standard deviation. Where unavailable, the range represents the IPAP/EPAP/CPAP settings described in the Methods. NA: not applicable </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">NPPV intervention summary: EPAP, IPAP, and PEEP settings, duration of therapy.</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005351-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Standard medical therapy for each trial</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lasix</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lasix dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nitrate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>FiO<sub>2</sub> mask and %FiO<sub>2</sub> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Other</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Additional differences between SMC received in treatment group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). "><b>Agmy 2008</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. "><b>Austin 2013</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual 400 ‐ 1600 mcg q5min</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, 8 ‐ 15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 1 ‐ 2 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. "><b>Crane 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitrates</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes, 10 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>diamorphine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). "><b>Ducros 2011</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lasix 40 mg ‐ 120 mg IV or 1 ‐ 3 mg bumetanide</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin (1 mg per 3 min) and a continuous IV infusion unless systolic BP &lt; 110 mmHg </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] "><b>El‐Refay 2016</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lasix 40 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin 0.4 mg sublingual</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 2 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. "><b>Frontin 2011</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mg/kg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>isosorbide dinitrate IV 2 mg if SBP &gt; 180 mmHg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). "><b>Gray 2008</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 mg above usual dose to max 100 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal nitrates 2 ‐ 5 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opiates</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. "><b>Hao 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 ‐ 40 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal nitrates 0.5 mg to 1 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 2 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. "><b>Kelly 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 ‐ 100 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>buccal nitrate 5 mg if systolic BP &gt; 90 mmHg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>oxygen 60% by venturi mask</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>morphine IV 2.5 ‐ 10 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. "><b>Li 2005</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mask high concentration</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. "><b>Levitt 2001</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mask high flow</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. "><b>L'Her 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin IV infusion 1 mg/hour</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 2 ‐ 10 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. "><b>Lin 1991</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 100% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. "><b>Lin 1995</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg IV or double home dose</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nitroglycerin sublingual 0.6 mg or isosorbide 10 ‐ 20 mg, or nitro infusion 10 ‐ 50 mcg/min </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 100% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 2 ‐ 10 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. "><b>Masip 2000</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV glyceryl trinitrate 1mg if systolic BP &gt; 180 mmHg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 50% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine 4 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] "><b>Moritz 2003</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg IV or double home dose</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV nitroglycerin infusion 0.125 ‐ 0.25 mcg/kg/min</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 100% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] "><b>Nava 2003</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg IV or double usual dose, repeated, if necessary, every 20 mins, up to 320 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>continuous glyceryl trinitrate at an initial rate of 1.5 mg/hour. A bolus dose of 1 mg IV was added if systolic BP &gt; 180 mmHg </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>morphine sulphate up to 4 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] "><b>Park 2001</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 mg isosorbide dinitrite if systolic BP &gt; 100 mm Hg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] "><b>Park 2004</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 mg isosorbide dinitrate was given sublingually and if necessary titrated up to 15 mg </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 50% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] "><b>Räsänen 1985</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 ‐ 80 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroprusside, nitroglycerine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 30% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] "><b>Takeda 1997</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroglycerin infusion</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO2 50%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] "><b>Takeda 1998</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroglycerin infusion</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FiO<sub>2</sub> 70% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Morphine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] "><b>Thys 2002</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 mg IV</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>isosorbide dinitrate 2 mg/hour</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] "><b>Zokaei 2016</b> </a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 ‐ 320 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IV nitroglycerin 5 ‐ 50 mcg/kg/min</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 Lpm</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>morphine 5 ‐ 10 mg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>BP: blood pressure; FiO<sub>2</sub>: fraction of inspired oxygen; IV: intravenous; Lpm: litres per minute; NA: not available; mcg: micrograms; mcg/kg/min: micrograms per kilogram per minute; mg: milligrams; min: minutes; mmHg = millimetres of mercury </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Standard medical therapy for each trial</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005351-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">In‐hospital mortality duration of follow‐up</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up (days)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). "><b>Agmy 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. "><b>Austin 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. "><b>Crane 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). "><b>Ducros 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] "><b>El‐Refay 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. "><b>Frontin 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). "><b>Gray 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0008" title="HaoCX , LuoXR , LiuYM . Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure by nasal face mask. Acta Academiae Medicinae Jiangxi2002;42(5):48‐50. "><b>Hao 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0009" title="KellyCA , NewbyDE , McDonaghTA , MacKayTW , BarrJ , BoonNA , et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. European Heart Journal2002;23(17):1379‐86. "><b>Kelly 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0012" title="LiXK , ZhaoWH . The treatment of acute cardiogenic pulmonary edema with noninvasive positive pressure ventilation. Chongqing Medical Journal2005;34(4):575‐6. "><b>Li 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. "><b>Levitt 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. "><b>L'Her 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. "><b>Lin 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. "><b>Lin 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. "><b>Masip 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0016" title="MoritzF , BenichouJ , VanhestM , RichardJC , LineS , HellotMF , et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. European Journal of Emergency Medicine2003;10(3):204‐8. [PUBMED: 12972896] "><b>Moritz 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] "><b>Nava 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] "><b>Park 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] "><b>Park 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] "><b>Räsänen 1985</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] "><b>Takeda 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] "><b>Takeda 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] "><b>Thys 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.6<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] "><b>Zokaei 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p><sup>a</sup>Estimated based on longest reported mean hospital length of stay; <sup>b</sup>Based on latest death reported in trial </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">In‐hospital mortality duration of follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005351-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Intubation criteria for trials reporting endotracheal intubation rates</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intubation Criteria</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0001" title="AgmyG . The effect of CPAP and NPPV on acute pulmonary edema due to systolic diastolic or valvular heart failure. European Respiratory Journal2007;30(Suppl 51):321. AgmyG , MakhloufH , MohammedA , GhanemM , MohammedH . CPAP versus BiPAP in acute cardiogenic pulmonary edema experience with 129 patients. European Respiratory Society Annual Congress; 2008‐10‐04; Berlin, Germany. 2008. AgmyGM . The effect of CPAP and NPPV on acute cardiogenic pulmonary edema due to systolic, diastolic or valvular heart failure. American Thoracic Society International Conference. 2007 May 18‐23; San Francisco (CA). 2007; Vol. 1:A963. NCT00912158 . Non invasive mechanical ventilation in acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00912158 (first received 3 June 2009). "><b>Agmy 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0002" title="ACTRN12609000410257 . A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre‐hospital setting (public title) [A randomized clinical trial assessing survival rates in patients with acute cardiogenic pulmonary oedema (ACPO) who are treated with continuous positive airway pressure (CPAP) in the pre‐hospital setting (scientific title)]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83909 (first received 9 May 2009). AustinMA , WillsKE , KilpatrickD , GibsonM , WaltersEH . Effect of continuous positive airway pressure (CPAP) on mortality in the treatment of acute cardiogenic pulmonary oedema (ACPO) in the pre‐hospital setting: randomised controlled trial. Emergency Medicine Australasia2013;25(S1):1‐14. "><b>Austin 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0003" title="CraneSD , ElliottMW , GilliganP , RichardsK , GrayAJ . Randomized controlled comparison of continuous positive airway pressure, bilevel non‐invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emergency Medicine Journal2004;21(2):155‐61. "><b>Crane 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR &gt; 40, RR &lt; 10, altered level of consciousness, arterial pH &lt; 7.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0004" title="DucrosL , LogeartD , VicautE , HenryP , PlaisanceP , ColletJP , et al. CPAP for acute cardiogenic pulmonary oedema from out‐of‐hospital to cardiac intensive care unit: a randomised multicentre study. Intensive Care Medicine2011;37(9):1501‐9. [PUBMED: 21805159] NCT00554580 . Continuous positive airway pressure for acute pulmonary edema (CPAP). clinicaltrials.gov/ct2/show/NCT00554580 (First received 7 November 2007). "><b>Ducros 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SpO<sub>2</sub> &lt; 85% after 30 mins of 15 Lpm or FiO<sub>2</sub> 60% CPAP, respiratory arrest, psychomotor agitation, SBP &lt; 80 mmHg </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0005" title="ACTRN12614001208695 . Comparison of bilevel and continuous positive airway pressure noninvasive ventilation in acute cardiogenic pulmonary edema [Efficacy of noninvasive bilevel versus continuous positive airway pressure on blood gases in acute cardiogenic pulmonary edema: a single blinded randomized trial]. www.anzctr.org.au/ACTRN12614001208695.aspx (First received 6 Oct 2014). El‐RefayBH , GwadaRF , IbrahimBS . Bi‐level versus continuous positive airway pressure in acute cardiogenic pulmonary edema: a randomized control trial. Clinical Medicine Research2015;4(6):221‐28. [DOI: 10.11648/j.cmr.20150406.19] "><b>El‐Refay 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0006" title="FrontinP , BounesV , Houzé‐CerfonCH , CharpentierS , Houzé‐CerfonV , DucasséJL . Continuous positive airway pressure for cardiogenic pulmonary edema: a randomized study. American Journal of Emergency Medicine2011;29(7):775‐81. NCT00439075 . Randomised controlled comparison of continuous positive airway pressure (CPAP) with standard treatment in out‐of‐hospital patients with acute cardiogenic pulmonary edema. clinicaltrials.gov/ct2/show/NCT00439075 First received 23 February 2007. "><b>Frontin 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Worsening SpO<sub>2</sub> despite effective treatment, loss of airway protective reflexes (cough, swallow), decreased level of consciousness, haemodynamic instability, intolerance/poor fit of face mask for the CPAP group, medical clinical impression of deterioration, or participant request </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0007" title="GrayA , GoodacreS , NewbyDE , MassonM , SampsonF , NichollJ . Noninvasive ventilation in acute cardiogenic pulmonary edema. New England Journal of Medicine2008;359(2):142‐51. GrayAJ , GoodacreS , NewbyDE , MassonMA , SampsonF , DixonS , et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non‐invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technology Assessment2009;13(33):1‐106. ISRCTN07448447 . The effect of continuous positive airway pressure (CPAP) and non‐invasive positive pressure ventilation (NIPPV) in acute cardiogenic pulmonary oedema (ACPO) [3CPO]. isrctn.com/ISRCTN07448447 (First received 25 April 2003). "><b>Gray 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At discretion of treating clinician</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0010" title="L'HerE , DuquesneF , GirouE , RosiereXD , LeConteP , RenaultS , et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine2004;30(5):882‐8. "><b>L'Her 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiac or respiratory arrest, severe haemodynamic instability (SBP &lt; 80), administration of epinephrine/norepinephrine, refractory hypoxaemia SaO<sub>2</sub> &lt; 92% despite face mask, clinical signs of respiratory exhaustion (accessory muscle use with paradoxical abdominal motion), coma or seizures, agitation requiring sedation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0011" title="LevittMA . A prospective, randomized trial of BiPAP in severe acute congestive heart failure. Journal of Emergency Medicine2001;21(4):363‐9. "><b>Levitt 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical or arterial blood gas findings. Severe respiratory distress, deterioration in mental status, or further deterioration in vital signs with increasing HR, RR, or a decrease in BP. Decrease in pO<sub>2</sub> &lt; 60 or rise in pCO<sub>2</sub> &gt; 50 along with signs of clinical deterioration warranted intubation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0013" title="LinM , ChiangH . The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Journal of the Formosan Medical Association1991;90(8):736‐43. "><b>Lin 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinician discretion. Loss of consciousness or airway obstruction were indications for intubation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0014" title="LinM , YangY , ChiangH , ChangM , ChiangBN , CheitlinMD . Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest1995;107(5):1379‐86. "><b>Lin 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiopulmonary resuscitation or clinical deterioration with any 2 of the following: (1) a rise in arterial carbon dioxide tension to more than 55 mm Hg; (2) arterial blood oxygen partial pressure divided by fraction of inspired oxygen content less than 200 mm Hg; and (3) respiratory rate over 35 breaths/min. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0015" title="MasipJ , BetbeséAJ , PaézJ , VecillaF , CañizaresR , PadróJ , et al. Non‐invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet2000;356:2126‐32. "><b>Masip 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patients were intubated when the criteria for treatment failure were met. Details not specified. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0017" title="CarboneG , DiBattistaN , NavaS . Noninvasive bilevel ventilation vs conventional therapy in the treatment of acute cardiogenic pulmonary edema: a randomized controlled study. European Respiratory Journal2000;16:A3815. NavaS . Bilevel ventilation reduces the rate of endotracheal intubation in the hypercapnic, but not in the hypoxemic patients during acute respiratory failure due to cardiogenic pulmonary edema: a multicenter randomized study vs standard medical therapy. European Respiratory Journal2001;18:A184s. NavaS , CarboneG , DiBattistaN , BelloneA , BaiardiP , CosentiniR , et al. Noninvasive ventilation in cardiogenic pulmonary edema. American Journal of Respiratory and Critical Care Medicine2003;168(12):1432‐7. [MEDLINE: 12958051] "><b>Nava 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0018" title="ParkM . Randomized prospective trial of oxygen, continuous and bilevel positive airway pressure in the treatment of cardiogenic acute pulmonary edema. American Journal of Respiratory and Critical Care Medicine2002;165(Suppl 8):A27. ParkM , Lorenzi‐FilhoG , FeltrimMI , VieciliPR , SangeanMC , VolpeM , et al. Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arquivos Brasileiros de Cardiologia2001;76(3):226‐30. [PUBMED: 11262572] "><b>Park 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical judgement</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0019" title="ParkM , SangeanMC , VolpeMS , FeltrimMIZ , NozawaE , LeitePF , et al. Randomized, prospective trial of oxygen, continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Critical Care Medicine2004;32(12):2407‐15. [PUBMED: 15599144] "><b>Park 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical judgement</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0020" title="RäsänenJ , HeikkiläJ , DownsJ , NikkiP , VäisänenI , ViitanenA . Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. American Journal of Cardiology1985;55(4):296‐300. [PUBMED: 3881920] "><b>Räsänen 1985</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical judgement. Loss of consciousness or airway obstruction were indications for intubation at any time. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0021" title="TakedaS , TakanoT , OgawaR . The effect of nasal continuous positive airway pressure on plasma endothelin‐1 concentrations in patients with severe cardiogenic pulmonary edema. Anesthesia and Analgesia1997;84(5):1091‐6. [PUBMED: 9141937] "><b>Takeda 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical deterioration and either a decrease in the PaO<sub>2</sub>/FiO<sub>2</sub> &lt; 100 with an FIO<sub>2</sub> ≥ 70% or a increase in the PaCO<sub>2</sub> &gt; 55 mmHg </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0022" title="TakedaS , NeijimaJ , TakanoT , NakanishiK , TakayamaM , SakamotoA , et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Japanese Circulation Journal1998;62(8):553‐8. [PUBMED: 9741730] "><b>Takeda 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical deterioration and either a fall in PaO<sub>2</sub>/FiO<sub>2</sub> &lt; 100 with an FiO<sub>2</sub> of 70% or a rise in PaCO<sub>2</sub> to &gt; 55 mmHg. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0023" title="ThysF , RoeselerJ , ReynaertM , LiistroG , RodensteinDO . Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo‐controlled trial. European Respiratory Journal2002;20(3):545‐55. [PUBMED: 12358327] "><b>Thys 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Deterioration in clinical status including all of the following: dyspnoea, respiratory or heart frequency or both, sweating and agitation or deterioration in blood gases or in haemodynamic status or both </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005351-bbs2-0024" title="ZokaeiA , AhmadiSJ , HemmatiN . Noninvasive Pressure Control Inverse Ratio Ventilation (NIPCIRV) versus conventional oxygen therapy for treatment of acute cardiogenic pulmonary edema. Research Journal of Medical Sciences2016;10(5):449‐52. [DOI: 10.3923/rjmsci.2016.449.452] "><b>Zokaei 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR after 1 hour of bilevel NPPV &gt; 30, persistent hypoxaemia, haemodynamic instability (systolic BP &lt; 70), agitation, or worsened neurologic status, inability to tolerate mask or aspiration of gastric content </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>BP: blood pressure; CPAP: continuous positive airway pressure; FiO<sub>2</sub>: fraction of inspired oxygen; HR: heart rate; Lpm: litres per minute; PaCO<sub>2</sub>: arterial partial pressure of carbon dioxide; PaO<sub>2</sub>: arterial partial pressure of oxygen; RR: respiratory rate; SBP: systolic blood pressure </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Intubation criteria for trials reporting endotracheal intubation rates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/full#CD005351-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005351-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NPPV vs SMC</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 HOSPITAL MORTALITY <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2484</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.51, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Hospital mortality ‐ by NPPV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2484</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.58, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 CPAP vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.48, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 bilevel NPPV vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1030</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.53, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Hospital mortality ‐ by location <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2484</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.51, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 ER</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1596</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.47, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 ICU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.35, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.94 [0.09, 43.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Hospital mortality ‐ by baseline PaCO<sub>2</sub> <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2484</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.51, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 PaCO2 &lt;= 45mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.27, 0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 PaCO2 &gt; 45mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1903</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.65, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Hospital mortality ‐ sensitivity analysis (low risk of bias) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.61, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Hospital mortality ‐ sensitivity analysis (missing data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.54, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Hospital mortality ‐ sensitivity analysis (fixed‐effect) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2484</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.55, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 ETI RATE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.38, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 ETI rate ‐ by NPPV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.39, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 CPAP vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.34, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Bilevel NPPV vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1036</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.31, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 ETI rate ‐ by location <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.38, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 ER</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1561</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.37, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 ICU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.29, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.13, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 ETI rate ‐ by baseline PaCO<sub>2</sub> <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.38, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 PaCO2 &lt;= 45mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.26, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 PaCO2 &gt; 45mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1926</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.46, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 ETI rate ‐ sensitivity analysis (low risk of bias) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1491</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.55, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 ETI rate ‐ sensitivity analysis (missing data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.40, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 ETI rate ‐ by face mask type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.38, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Exclusive full face mask use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.40, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Exclusive or permissive nasal mask use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.20, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 ACUTE MI INCIDENCE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.91, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Acute MI incidence ‐ by NPPV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.91, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 CPAP vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>569</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.80, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 bilevel NPPV vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>744</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.92, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 HOSPITAL LENGTH OF STAY <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1714</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐1.23, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Hospital length of stay ‐ by NPPV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1714</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐1.02, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 CPAP vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>943</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.77, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 bilevel NPPV vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>771</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [‐0.35, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Hospital length of stay ‐ by location <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1714</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.21, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 ER</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1455</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐1.70, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 ICU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐1.30, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Hospital length of stay ‐ by baseline PaCO<sub>2</sub> <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1714</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.21, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 PaCO2 &lt;= 45mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.18 [‐2.33, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 PaCO2 &gt; 45mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐0.15, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 ICU LENGTH OF STAY <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 SYSTOLIC BP AFTER ONE HOUR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1408</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.72 [‐5.03, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Systolic BP after one hour ‐ by NPPV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1408</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.72 [‐5.03, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 CPAP vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>866</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.65 [‐5.58, 2.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 bilevel NPPV vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.89 [‐8.01, 4.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 DIASTOLIC BP AFTER ONE HOUR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1361</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [‐1.86, 4.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Diastolic BP after one hour ‐ by NPPV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1361</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [‐2.15, 4.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.1 CPAP vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [‐3.92, 5.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.2 bilevel NPPV vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [‐2.88, 5.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 MEAN BP AFTER ONE HOUR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.50 [‐8.29, 3.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 RESPIRATORY RATE AFTER ONE HOUR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.87 [‐2.70, ‐1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Respiratory rate after one hour ‐ by NPPV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.58 [‐2.22, ‐0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 CPAP vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.64 [‐2.41, ‐0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.2 bilevel NPPV vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>529</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.17 [‐4.69, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 PaO<sub>2</sub> (mmHg) AFTER ONE HOUR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1428</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.19 [3.54, 28.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 PaO<sub>2</sub> (mmHg) after one hour ‐ by NPPV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1428</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.74 [2.72, 24.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 CPAP vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>761</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.55 [‐9.10, 28.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.2 bilevel NPPV vs SMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.50 [4.29, 34.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 ADVERSE EVENTS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9570</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.73, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 Skin damage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.09 [0.74, 111.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.2 Pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.05, 5.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.3 Gastrointestinal bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [0.35, 15.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.4 Gastric distention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.26 [0.82, 215.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.5 Vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1467</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.49, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.6 Pneumothorax</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.08, 6.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.7 Sinusitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.12, 72.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.8 Discomfort with mask</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.59 [2.39, 66.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.9 Hypotension</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1030</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.58, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.10 Arrhythmia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1027</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.50, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.11 Cardiorespiratory arrest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.34, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.12 Gastric aspiration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1037</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [0.06, 38.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.13 Stroke</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.14 Seizures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.15 Claustrophobia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.12, 72.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.16 Hypercapnia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>299</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.16, 3.62]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NPPV vs SMC</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005351.pub4/references#CD005351-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005351.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005351-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005351-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD005351-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD005351-note-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD005351-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD005351-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD005351-note-0016">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD005351-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD005351-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD005351-note-0002">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005351\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005351\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005351\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005351\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005351\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZCrlluee&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005351.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005351.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005351.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005351.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005351.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727919275"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005351.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727919279"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005351.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb7d01c7e937f',t:'MTc0MDcyNzkxOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 